var title_f39_35_40496="Calculator: Pulmonary embolism Wells score";
var content_f39_35_40496=[" <div id=\"topicText\">",
"  <div id=\"mc3k\">",
"   <form action=\"\" id=\"PulmonaryEmbRisk_form\" name=\"PulmonaryEmbRisk_form\" onreset=\"rrclr();\" onsubmit=\"return false;\">",
"    <table cellpadding=\"4\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\" width=\"100%\">",
"     <tr>",
"      <td bgcolor=\"#eeeeee\" width=\"1%\">",
"       <br/>",
"      </td>",
"      <td align=\"left\" bgcolor=\"#eeeeee\">",
"       <span class=\"medCalcFontTitleBox\">",
"        Calculator: Pulmonary embolism Wells score",
"       </span>",
"      </td>",
"     </tr>",
"    </table>",
"    <br/>",
"    &nbsp;",
"    <br/>",
"    <div id=\"calc_main\">",
"     <div id=\"calc_input\">",
"      <center>",
"       <table cellpadding=\"3\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\">",
"        <tr>",
"         <td width=\"20\">",
"          <br/>",
"         </td>",
"         <td align=\"right\">",
"          <input name=\"cc1\" onclick=\"PulmonaryEmbRisk_fx();\" type=\"checkbox\"/>",
"         </td>",
"         <td align=\"left\">",
"          <span class=\"medCalcFontCCTab\">",
"           Symptoms of DVT (3 points)",
"          </span>",
"         </td>",
"        </tr>",
"        <tr>",
"         <td width=\"20\">",
"          <br/>",
"         </td>",
"         <td align=\"right\">",
"          <input name=\"cc2\" onclick=\"PulmonaryEmbRisk_fx();\" type=\"checkbox\"/>",
"         </td>",
"         <td align=\"left\">",
"          <span class=\"medCalcFontCCTab\">",
"           No alternative diagnosis better explains the illness (3 points)",
"          </span>",
"         </td>",
"        </tr>",
"        <tr>",
"         <td width=\"20\">",
"          <br/>",
"         </td>",
"         <td align=\"right\">",
"          <input name=\"cc3\" onclick=\"PulmonaryEmbRisk_fx();\" type=\"checkbox\"/>",
"         </td>",
"         <td align=\"left\">",
"          <span class=\"medCalcFontCCTab\">",
"           Tachycardia with pulse &gt;100 (1.5 points)",
"          </span>",
"         </td>",
"        </tr>",
"        <tr>",
"         <td width=\"20\">",
"          <br/>",
"         </td>",
"         <td align=\"right\">",
"          <input name=\"cc4\" onclick=\"PulmonaryEmbRisk_fx();\" type=\"checkbox\"/>",
"         </td>",
"         <td align=\"left\">",
"          <span class=\"medCalcFontCCTab\">",
"           Immobilization (&gt;=3 days) or surgery in the previous four weeks (1.5 points)",
"          </span>",
"         </td>",
"        </tr>",
"        <tr>",
"         <td width=\"20\">",
"          <br/>",
"         </td>",
"         <td align=\"right\">",
"          <input name=\"cc5\" onclick=\"PulmonaryEmbRisk_fx();\" type=\"checkbox\"/>",
"         </td>",
"         <td align=\"left\">",
"          <span class=\"medCalcFontCCTab\">",
"           Prior history of DVT or pulmonary embolism (1.5 points)",
"          </span>",
"         </td>",
"        </tr>",
"        <tr>",
"         <td width=\"20\">",
"          <br/>",
"         </td>",
"         <td align=\"right\">",
"          <input name=\"cc6\" onclick=\"PulmonaryEmbRisk_fx();\" type=\"checkbox\"/>",
"         </td>",
"         <td align=\"left\">",
"          <span class=\"medCalcFontCCTab\">",
"           Presence of hemoptysis (1 point)",
"          </span>",
"         </td>",
"        </tr>",
"        <tr>",
"         <td width=\"20\">",
"          <br/>",
"         </td>",
"         <td align=\"right\">",
"          <input name=\"cc7\" onclick=\"PulmonaryEmbRisk_fx();\" type=\"checkbox\"/>",
"         </td>",
"         <td align=\"left\">",
"          <span class=\"medCalcFontCCTab\">",
"           Presence of malignancy (1 point)",
"          </span>",
"         </td>",
"        </tr>",
"       </table>",
"      </center>",
"     </div>",
"     <br/>",
"     &nbsp;",
"     <br/>",
"     <div id=\"calc_result\">",
"      <span class=\"medCalcFontCCTabBold\">",
"       Total Criteria Point Count:",
"      </span>",
"      <input name=\"cctotal\" onfocus=\"blur();\" size=\"6\" type=\"text\"/>",
"      <br/>",
"      &nbsp;",
"      <br/>",
"      <center>",
"       <input name=\"reset\" type=\"reset\" value=\"Reset Form\"/>",
"      </center>",
"      <br/>",
"      &nbsp;",
"      <br/>",
"      <table cellpadding=\"4\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\" width=\"70%\">",
"       <tr>",
"        <td bgcolor=\"#eeeeee\" width=\"1%\">",
"         <br/>",
"        </td>",
"        <td align=\"left\" bgcolor=\"#eeeeee\">",
"         <span class=\"medCalcFontTitleBox\">",
"          Pulmonary Embolism Risk Score Interpretation",
"         </span>",
"        </td>",
"       </tr>",
"      </table>",
"      <br/>",
"      &nbsp;",
"      <br/>",
"      <center>",
"       <table border=\"1\" cellpadding=\"4\" cellspacing=\"0\" summary=\"RRTable\">",
"        <tr id=\"rr1_1\">",
"         <td align=\"right\" nowrap=\"nowrap\" style=\"border-right: 0px;\">",
"          <span class=\"medCalcFontOneBold\">",
"           Score &gt;6:",
"          </span>",
"         </td>",
"         <td align=\"left\" style=\"border-left: 0px;\">",
"          <span class=\"medCalcFontOne\">",
"           High probability",
"          </span>",
"         </td>",
"        </tr>",
"        <tr id=\"rr1_2\">",
"         <td align=\"right\" nowrap=\"nowrap\" style=\"border-right: 0px;\">",
"          <span class=\"medCalcFontOneBold\">",
"           Score &gt;=2 and &lt;=6:",
"          </span>",
"         </td>",
"         <td align=\"left\" style=\"border-left: 0px;\">",
"          <span class=\"medCalcFontOne\">",
"           Moderate probability",
"          </span>",
"         </td>",
"        </tr>",
"        <tr id=\"rr1_3\">",
"         <td align=\"right\" nowrap=\"nowrap\" style=\"border-right: 0px;\">",
"          <span class=\"medCalcFontOneBold\">",
"           Score &lt;2:",
"          </span>",
"         </td>",
"         <td align=\"left\" style=\"border-left: 0px;\">",
"          <span class=\"medCalcFontOne\">",
"           Low Probability",
"          </span>",
"         </td>",
"        </tr>",
"       </table>",
"      </center>",
"     </div>",
"    </div>",
"    <br/>",
"    &nbsp;",
"    <br/>",
"    <div id=\"calc_hints\">",
"     <span class=\"medCalcFontOne\">",
"      The article referenced below also refers to a cut point of 4 points or less as PE unlikely as long as the specific D-Dimer test",
"is negative.  Refer to the original article below for all details.",
"     </span>",
"    </div>",
"    <br/>",
"    &nbsp;",
"    <br/>",
"    <div id=\"calc_refs\">",
"     <span class=\"medCalcFontRef\">",
"      <b>",
"       References",
"      </b>",
"     </span>",
"     <ol>",
"      <li>",
"       <span class=\"medCalcFontRef\">",
"        Wells PS, Anderson DR, Rodger M, et. al. Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer.",
"        <i>",
"         Thromb Haemost",
"        </i>",
"        . 2000 Mar;83(3):416-20.",
"       </span>",
"      </li>",
"     </ol>",
"    </div>",
"   </form>",
"   <script language=\"JavaScript1.1\" type=\"text/javascript\">",
"    &lt;!--",
"",
";",
"PulmonaryEmbRisk_fx();",
"//--&gt;",
"   </script>",
"  </div>",
" </div>",
" <div id=\"topicAgreement\">",
"  Use of UpToDate is subject to the",
"  <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"   Subscription and License Agreement",
"  </a>",
"  .",
" </div>",
" <div id=\"printDisclaimer\">",
"  Information on this page may not appear correctly if printed.",
" </div>",
" <div id=\"disclaimerCalculator\">",
"  <div class=\"medCalcFontTwo\">",
"   <p class=\"header\">",
"    Legal Notices and Disclaimer",
"   </p>",
"   <p>",
"    All information contained in and produced by the MedCalc 3000 system is provided",
"			for educational purposes only. This information should not be used for the diagnosis or treatment",
"			of any health problem or disease.",
"    <b>",
"     THIS INFORMATION IS NOT INTENDED TO REPLACE CLINICAL JUDGMENT OR",
"			GUIDE INDIVIDUAL PATIENT CARE IN ANY MANNER.",
"    </b>",
"    <a class=\"medCalcDisclaimerLink\" href=\"./med-calc-disclaimer\">",
"     Click here for",
"				full notice and disclaimer.",
"    </a>",
"   </p>",
"   <p class=\"copy\">",
"    MedCalc 3000 is Copyright &copy; 1998-2013 Foundation Internet Services",
"   </p>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_35_40496=[" ",
"",
"var calctxt = '';",
"var xmltxt = '';",
"var htmtxt = '';",
"",
"",
"function PulmonaryEmbRisk_fx() {",
"with(document.PulmonaryEmbRisk_form){",
"",
"Score = 0.0;",
"doCalc = true;",
"",
"if (cc1.checked){",
"Score = Score + 3;",
"}",
"if (cc2.checked){",
"Score = Score + 3;",
"}",
"if (cc3.checked){",
"Score = Score + 1.5;",
"}",
"if (cc4.checked){",
"Score = Score + 1.5;",
"}",
"if (cc5.checked){",
"Score = Score + 1.5;",
"}",
"if (cc6.checked){",
"Score = Score + 1;",
"}",
"if (cc7.checked){",
"Score = Score + 1;",
"}",
"cctotal.value = Score;",
"",
"if (doCalc){",
"rrclr();",
"if (Score >6){ document.getElementById('rr1_1').bgColor = '#cccccc';",
"}",
"if ((Score >=2) && (Score <=6)){ document.getElementById('rr1_2').bgColor = '#cccccc';",
"}",
"if (Score <2){ document.getElementById('rr1_3').bgColor = '#cccccc';",
"}",
"",
"}",
"}",
"}",
"",
"",
"",
"",
"function rrclr(){",
"document.getElementById('rr1_1').bgColor = \"\";",
"document.getElementById('rr1_2').bgColor = \"\";",
"document.getElementById('rr1_3').bgColor = \"\";",
"}",
"",
"",
""].join("\n");
var outline_f39_35_40496=null;
var title_f39_35_40497="Ambroxol: International drug information";
var content_f39_35_40497=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Ambroxol: International drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F4323400\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Ambroten (BR);",
"     </li>",
"     <li>",
"      Ambroxol Basics (DE);",
"     </li>",
"     <li>",
"      Benflux (PT);",
"     </li>",
"     <li>",
"      Fluibron (BR);",
"     </li>",
"     <li>",
"      Fluidin (BR);",
"     </li>",
"     <li>",
"      Mucibron (BR);",
"     </li>",
"     <li>",
"      Mucodrenol (PT);",
"     </li>",
"     <li>",
"      Mucolin (BR);",
"     </li>",
"     <li>",
"      Tabcin (AR);",
"     </li>",
"     <li>",
"      Vaksan (AR)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list synlist drugH1Div drugBrandNames\" id=\"F1977675\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Index Terms",
"    </span>",
"    <ul>",
"     <li>",
"      Ambroxol Hydrochloride",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1977679\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Mucolytic Agent",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block iuse drugH1Div\" id=\"F1977682\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reported Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of acute and chronic respiratory tract disorders associated with viscid mucus",
"    </p>",
"   </div>",
"   <div class=\"block idos drugH1Div\" id=\"F1977677\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Range",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Adults: Oral: 60-120 mg/day in 2 divided doses",
"    </p>",
"   </div>",
"   <div class=\"block prod-avail drugH1Div\" id=\"F11821160\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Product Availability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Product available in various countries; not currently available in the U.S.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F1977681\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet: 30 mg",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10520 Version 28.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-58.240.98.179-8913731101-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_35_40497=[""].join("\n");
var outline_f39_35_40497=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4323400\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1977675\">",
"      Index Terms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1977679\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1977682\">",
"      Reported Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1977677\">",
"      Dosage Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11821160\">",
"      Product Availability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1977681\">",
"      Dosage Forms",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_INT/10520\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_INT/10520|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f39_35_40498="Combined Phalen wrist compression test";
var content_f39_35_40498=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F86754&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F86754&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 591px\">",
"   <div class=\"ttl\">",
"    Combined Phalen and compression test of the wrist",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 571px; height: 380px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Combining the Phalen and compression tests is another way to look for signs of carpal tunnel syndrome. The test is performed by holding the patients wrist in flexion while applying direct pressure over the patient&rsquo;s median nerve.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Blake Boggess, DO.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_35_40498=[""].join("\n");
var outline_f39_35_40498=null;
var title_f39_35_40499="Esoph superficial dissecans";
var content_f39_35_40499=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F68821&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F68821&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Esophagitis dissecans superficialis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 339px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Upper endoscopy showing a denuded esophagus in esophagitis dissecans superficialis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of S. Ian Gan, MD, and Daniel Wild, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_35_40499=[""].join("\n");
var outline_f39_35_40499=null;
var title_f39_35_40500="Other disorders of glycogen metabolism: GLUT2 deficiency and aldolase A deficiency";
var content_f39_35_40500=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Other disorders of glycogen metabolism: GLUT2 deficiency and aldolase A deficiency",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/35/40500/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/35/40500/contributors\">",
"     William J Craigen, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/35/40500/contributors\">",
"     Basil T Darras, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/35/40500/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/35/40500/contributors\">",
"     Sihoun Hahn, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/35/40500/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/35/40500/contributors\">",
"     Elizabeth TePas, MD, MS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?39/35/40500/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 13, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Glycogen is the stored form of glucose and serves as a buffer for glucose needs. It is composed of long polymers of a 1-4 linked glucose, interrupted by a 1-6 linked branch point every 4 to 10 residues. Glycogen is formed in periods of dietary carbohydrate loading and broken down when glucose demand is high or dietary availability is low (",
"    <a class=\"graphic graphic_figure graphicRef81164 \" href=\"mobipreview.htm?4/62/5089\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    There are a number of inborn errors of glycogen metabolism that result from mutations in genes for virtually all of the proteins involved in glycogen synthesis, degradation, or regulation (",
"    <a class=\"graphic graphic_figure graphicRef81164 \" href=\"mobipreview.htm?4/62/5089\">",
"     figure 1",
"    </a>",
"    ). Those disorders that result in abnormal storage of glycogen are known as glycogen storage diseases (GSDs) (",
"    <a class=\"graphic graphic_table graphicRef54417 \" href=\"mobipreview.htm?37/36/38477\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Glycogen is most abundant in liver and muscle. The major manifestations of disorders of glycogen metabolism affecting the liver are hypoglycemia and hepatomegaly, and the primary features of those defects that affect muscle are muscle cramps, exercise intolerance, easy fatigability, and progressive weakness.",
"   </p>",
"   <p>",
"    This topic will review two disorders of glycogen metabolism: glucose transporter 2 (GLUT2) deficiency and aldolase A deficiency. An overview of glycogen storage diseases is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/16/4356?source=see_link\">",
"     \"Overview of inherited disorders of glucose and glycogen metabolism\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     GLUT2 DEFICIENCY",
"    </span>",
"    &nbsp;&mdash;&nbsp;GLUT2 deficiency (MIM #227810), also known as Fanconi-Bickel syndrome, is a rare disorder of glucose homeostasis that leads to accumulation of glycogen in the liver and kidney and glucose and galactose intolerance. GLUT2 is a facilitative, bidirectional transporter. It passively transports intracellular glucose and galactose across the basolateral membrane of cells including hepatocytes, pancreatic beta cells, renal tubular cells, and intestinal epithelial cells by moving the carbohydrate molecule down its concentration gradient [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/35/40500/abstract/1\">",
"     1",
"    </a>",
"    ]. Transient expression of induced apical membrane GLUT2 plays a role separate from sodium-glucose transporter 1 (SGLT1 or SLC5A1) in the absorption of simple sugars in the intestinal mucosa and is a potential target for modulating carbohydrate absorption [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/35/40500/abstract/2\">",
"     2",
"    </a>",
"    ]. Glycogen accumulation in patients with GLUT2 deficiency occurs due to a failure to adequately export glucose generated by glycogen degradation. This inadequate export leads to a marked increase in intracellular glucose that inhibits glycogen degradation.(See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/46/41702?source=see_link&amp;anchor=H4#H4\">",
"     \"Insulin secretion and pancreatic beta-cell function\", section on 'Role of glucose'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Genetics",
"    </span>",
"    &nbsp;&mdash;&nbsp;The disorder is due to mutations in the gene for the glucose transporter GLUT2 (SLC2A2), located at 3q26 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/35/40500/abstract/3\">",
"     3",
"    </a>",
"    ]. Inheritance is autosomal recessive. The majority of cases occur in consanguineous families.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Clinical features",
"    </span>",
"    &nbsp;&mdash;&nbsp;Affected patients typically present in infancy with hepatomegaly secondary to glycogen accumulation, severe failure to thrive, and rickets [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/35/40500/abstract/4\">",
"     4",
"    </a>",
"    ]. Aberrant hepatocyte glucose transport results in postprandial hyperglycemia followed by fasting hypoglycemia. Glucose-stimulated insulin release is diminished and contributes to poor glucose control. HgbA1c is normal, and fasting hypoglycemia and postprandial hyperglycemia appear to improve with age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/35/40500/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients have a characteristic tubular nephropathy, with glucosuria, phosphaturia, bicarbonate wasting, and a generalized amino aciduria, leading to rickets [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/35/40500/abstract/4,6\">",
"     4,6",
"    </a>",
"    ]. Osmotic diuresis leads to polyuria. Short stature persists through adulthood [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/35/40500/abstract/7\">",
"     7",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/21/26967?source=see_link\">",
"     \"Overview of rickets in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Intellectual development is normal in patients with GLUT2 deficiency. Linear growth and puberty are delayed. While the underlying mechanisms have not been well documented in GLUT2 deficiency, endocrine abnormalities have been documented in other forms of hepatic glycogenoses that may be operative in GLUT2 deficiency [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/35/40500/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Clinical features of GLUT2 deficiency have considerable overlap with GSD Ia (glucose 6-phosphatase deficiency). However, severe hypoglycemia, lactic acidemia, or hyperuricemia are not present in GLUT2 deficiency and renal tubulopathy is seen only in GLUT2 deficiency.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of GLUT2 deficiency should be considered in a child with the symptoms described plus altered glucose homeostasis, accumulation of glycogen in the liver and a Fanconi-type tubulopathy. Tests of glucose and galactose tolerance and renal function are abnormal. Serum biotinidase activity may be increased, as is observed in other glycogen storage disorders [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/35/40500/abstract/9\">",
"     9",
"    </a>",
"    ]. Liver biopsy reveals increased glycogen content without significant inflammation or fibrosis. The diagnosis is confirmed by DNA analysis. The disorder may be detected by a newborn screening test that is positive for galactosemia, if the basis for screening is the direct measurement of galactose and not measurement of galactose-1-phosphate uridyl transferase (GALT) activity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/35/40500/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;No specific treatment is available. Management of the renal disease consists of supplementation of water, electrolytes, and vitamin D, and restriction of galactose. Frequent small meals with adequate caloric intake may improve growth. Treatment with uncooked cornstarch, a complex glucose polymer that is digested over several hours, before bedtime may help maintain glucose levels during sleep [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/35/40500/abstract/11\">",
"     11",
"    </a>",
"    ]. Young infants (&lt;six months) may develop gastrointestinal distress (colicky symptoms or diarrhea) as pancreatic amylase has not reached adult level.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     ALDOLASE A DEFICIENCY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Aldolase A deficiency (also called glycogen storage disease XII, GSD XII; MIM #611881) is a rare GSD associated with hereditary hemolytic anemia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27065237\">",
"    <span class=\"h2\">",
"     Pathogenesis",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the glycolytic pathway, three isozymes of aldolase (A, B, and C) are responsible for the conversion of fructose-1,6-biphosphate into glyceraldehyde-3-phosphate and dihydroxyacetone phosphate, and are encoded by distinct genes. Aldolase A in humans is encoded by a single gene on chromosome 16p11.2 and is a homotetrameric enzyme [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/35/40500/abstract/12,13\">",
"     12,13",
"    </a>",
"    ]. Aldolase A is the only isozyme present in both red blood cells and skeletal muscle.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Clinical and laboratory findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;To date, only a few patients have been reported with both hemolysis and myopathic symptoms. Two patients developed rhabdomyolysis during a febrile illness [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/35/40500/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. Additional manifestations during the acute illness included myopathic symptoms, hemolytic anemia, jaundice, and hyperkalemia. One of these children had initially presented with increasing muscle weakness and transfusion-dependent hemolytic anemia that was reversed following splenectomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/35/40500/abstract/15\">",
"     15",
"    </a>",
"    ]. Laboratory findings in one of the two children included a highly elevated serum creatinine kinase and markers of hemolysis, mild hemoglobinuria, and myoglobinuria [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/35/40500/abstract/14\">",
"     14",
"    </a>",
"    ]. Biochemical assays showed a profound reduction in red blood cell and skeletal muscle aldolase A level and also diminished thermostability of the residual enzyme. A third child with suspected hemolytic anemia had associated myopathic symptoms at birth, as well as arthrogryposis multiplex congenita and pituitary ectopia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/35/40500/abstract/16\">",
"     16",
"    </a>",
"    ]. Despite its rare occurrence, a history of hemolytic anemia and the development of myopathic symptoms",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    myoglobinuria in the setting of fever should alert the clinician to the possibility of aldolase A deficiency.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27065376\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Aldolase A activity is diminished in erythrocytes and muscle biopsy tissue of patients with aldolase A deficiency and hence enzymatic assays is typically used to make the diagnosis. The detection of a homozygous pathogenic mutation or two heterozygous mutations in the ALDOA gene by sequence analysis can also confirm the diagnosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27065391\">",
"    <span class=\"h2\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment of aldolase A deficiency remains supportive. Enzyme replacement therapy is not available. Patients are usually assessed first by a hematologist regarding the diagnosis and management of hemolytic anemia. During febrile episodes, patients with confirmed enzymatic",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    molecular diagnosis should be treated aggressively with antipyretics to diminish the risk of hemolysis and rhabdomyolysis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/60/43977?source=see_link\">",
"     \"Overview of hemolytic anemias in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27065406\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Inborn errors of glycogen metabolism include the inherited glycogen storage diseases (",
"      <a class=\"graphic graphic_table graphicRef54417 \" href=\"mobipreview.htm?37/36/38477\">",
"       table 1",
"      </a>",
"      ). The major manifestations of disorders of glycogen metabolism affecting the liver are hypoglycemia and hepatomegaly, and the primary features of those defects that affect muscle are muscle cramps, exercise intolerance and easy fatigability, and progressive weakness. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?4/16/4356?source=see_link\">",
"       \"Overview of inherited disorders of glucose and glycogen metabolism\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      GLUT2 deficiency, also known as Fanconi-Bickel syndrome, is a rare disorder of glucose homeostasis that leads to accumulation of glycogen in the liver and kidney and glucose and galactose intolerance. Affected patients typically present in infancy with hepatomegaly secondary to glycogen accumulation, severe failure to thrive, and rickets. No specific treatment is available, other than dietary management. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'GLUT2 deficiency'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Aldolase A deficiency, also called glycogen storage disease XII (GSD XII), is a rare GSD associated with hereditary hemolytic anemia. The most common findings are myopathic symptoms and hemolytic anemia. Rhabdomyolysis can occur during a febrile illness. Treatment of aldolase A deficiency includes management of hemolytic anemia and antipyretics during febrile episodes to decrease the risk of hemolysis and rhabdomyolysis. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Aldolase A deficiency'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40500/abstract/1\">",
"      Brown GK. Glucose transporters: structure, function and consequences of deficiency. J Inherit Metab Dis 2000; 23:237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40500/abstract/2\">",
"      Kellett GL, Brot-Laroche E, Mace OJ, Leturque A. Sugar absorption in the intestine: the role of GLUT2. Annu Rev Nutr 2008; 28:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40500/abstract/3\">",
"      Santer R, Schneppenheim R, Dombrowski A, et al. Mutations in GLUT2, the gene for the liver-type glucose transporter, in patients with Fanconi-Bickel syndrome. Nat Genet 1997; 17:324.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40500/abstract/4\">",
"      Santer R, Steinmann B, Schaub J. Fanconi-Bickel syndrome--a congenital defect of facilitative glucose transport. Curr Mol Med 2002; 2:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40500/abstract/5\">",
"      Taha D, Al-Harbi N, Al-Sabban E. Hyperglycemia and hypoinsulinemia in patients with Fanconi-Bickel syndrome. J Pediatr Endocrinol Metab 2008; 21:581.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40500/abstract/6\">",
"      Berry GT, Baker L, Kaplan FS, Witzleben CL. Diabetes-like renal glomerular disease in Fanconi-Bickel syndrome. Pediatr Nephrol 1995; 9:287.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40500/abstract/7\">",
"      Manz F, Bickel H, Brodehl J, et al. Fanconi-Bickel syndrome. Pediatr Nephrol 1987; 1:509.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40500/abstract/8\">",
"      Dunger DB, Holder AT, Leonard JV, et al. Growth and endocrine changes in the hepatic glycogenoses. Eur J Pediatr 1982; 138:226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40500/abstract/9\">",
"      Paesold-Burda P, Baumgartner MR, Santer R, et al. Elevated serum biotinidase activity in hepatic glycogen storage disorders--a convenient biomarker. J Inherit Metab Dis 2007; 30:896.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40500/abstract/10\">",
"      M&uuml;ller D, Santer R, Krawinkel M, et al. Fanconi-Bickel syndrome presenting in neonatal screening for galactosaemia. J Inherit Metab Dis 1997; 20:607.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40500/abstract/11\">",
"      Lee PJ, Van't Hoff WG, Leonard JV. Catch-up growth in Fanconi-Bickel syndrome with uncooked cornstarch. J Inherit Metab Dis 1995; 18:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40500/abstract/12\">",
"      Kikuta A, Yoshida MC, Sakakibara M, et al. Molecular gene mapping for the structural gene for human aldolase A (ALDOA) to chromosome 22. Cytogenet Cell Genet 1985; 40:674 (Abstract).",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40500/abstract/13\">",
"      Serero S, Maire P, Nguyen VC, et al. Localization of the active gene of aldolase on chromosome 16, and two aldolase A pseudogenes on chromosomes 3 and 10. Hum Genet 1988; 78:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40500/abstract/14\">",
"      Kreuder J, Borkhardt A, Repp R, et al. Brief report: inherited metabolic myopathy and hemolysis due to a mutation in aldolase A. N Engl J Med 1996; 334:1100.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40500/abstract/15\">",
"      Yao DC, Tolan DR, Murray MF, et al. Hemolytic anemia and severe rhabdomyolysis caused by compound heterozygous mutations of the gene for erythrocyte/muscle isozyme of aldolase, ALDOA(Arg303X/Cys338Tyr). Blood 2004; 103:2401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40500/abstract/16\">",
"      Esposito G, Vitagliano L, Costanzo P, et al. Human aldolase A natural mutants: relationship between flexibility of the C-terminal region and enzyme function. Biochem J 2004; 380:51.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2914 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-221.179.173.170-312020EB49-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_35_40500=[""].join("\n");
var outline_f39_35_40500=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H27065406\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      GLUT2 DEFICIENCY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Genetics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Clinical features",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      ALDOLASE A DEFICIENCY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27065237\">",
"      Pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Clinical and laboratory findings",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27065376\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27065391\">",
"      Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27065406\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ALLRG/2914\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/2914|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?4/62/5089\" title=\"figure 1\">",
"      Pathways of glycogen metabolism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/2914|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?37/36/38477\" title=\"table 1\">",
"      Disorders of glycogen - glucose metabolism",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/46/41702?source=related_link\">",
"      Insulin secretion and pancreatic beta-cell function",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/60/43977?source=related_link\">",
"      Overview of hemolytic anemias in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/16/4356?source=related_link\">",
"      Overview of inherited disorders of glucose and glycogen metabolism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/21/26967?source=related_link\">",
"      Overview of rickets in children",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f39_35_40501="Anatomy of tetralogy of Fallot";
var content_f39_35_40501=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F82493&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F82493&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 550px\">",
"   <div class=\"ttl\">",
"    Anatomy of tetralogy of Fallot",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 530px; height: 605px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Tetralogy of Fallot is characterized by a large ventricular septal defect&nbsp;(VSD), an aorta that overrides the left and right ventricles, obstruction of the right ventricular outflow tract, and right ventricular hypertrophy. As a result of the substantial obstruction of the right ventricular outflow tract, there is right to left shunting through the VSD resulting in cyanosis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     <p>",
"      &nbsp;",
"     </p>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_35_40501=[""].join("\n");
var outline_f39_35_40501=null;
var title_f39_35_40502="Pemphigus vulgaris large erosions";
var content_f39_35_40502=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F63170&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F63170&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Pemphigus vulgaris",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple erosions on the trunk skin of this patient with pemphigus vulgaris.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_35_40502=[""].join("\n");
var outline_f39_35_40502=null;
var title_f39_35_40503="Fondaparinux: Drug information";
var content_f39_35_40503=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Fondaparinux: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?37/8/38020?source=see_link\">",
"    see \"Fondaparinux: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block black-box-warn drugH1Div\" id=\"F5708809\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     ALERT: U.S. Boxed Warning",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The FDA-approved labeling includes a boxed warning. See Warnings/Precautions section for a concise summary of this information.  For verbatim wording of the boxed warning, consult the product labeling or",
"     <a href=\"file://www.fda.gov\" target=\"_blank\">",
"      www.fda.gov",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F174015\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Arixtra&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F174016\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Arixtra&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F174034\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Factor Xa Inhibitor",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F174018\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      DVT prophylaxis:",
"     </b>",
"     SubQ: Adults &ge;50 kg: 2.5 mg once daily.",
"     <b>",
"      Note:",
"     </b>",
"     Prophylactic use contraindicated in patients &lt;50 kg. Initiate dose after hemostasis has been established, 6-8 hours postoperatively.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      DVT prophylaxis with history of HIT (unlabeled use):",
"     </b>",
"     SubQ: 2.5 mg once daily (Blackmer, 2009; Harenberg, 2004; Parody, 2003)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Usual duration: 5-9 days (up to 10 days following abdominal surgery or up to 11 days following hip replacement or knee replacement). The American College of Chest Physicians recommends a minimum of 10-14 days for patients undergoing total hip arthroplasty, total knee arthroplasty, or hip fracture surgery; extended duration of up to 35 days suggested (Guyatt, 2012).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Acute DVT/PE treatment:",
"     </b>",
"     SubQ:",
"     <b>",
"      Note:",
"     </b>",
"     Start warfarin on the first or second treatment day and continue fondaparinux until INR is &ge;2 for at least 24 hours (usually 5-7 days) (Guyatt, 2012):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &lt;50 kg: 5 mg once daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     50-100 kg: 7.5 mg once daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &gt;100 kg: 10 mg once daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Usual duration: 5-9 days (has been administered up to 26 days)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Acute coronary syndrome (Canadian labeling; unlabeled use in U.S.):",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     UA/NSTEMI: SubQ: 2.5 mg once daily; initiate as soon as possible after presentation; treat for up to 8 days or until hospital discharge (Anderson, 2007; Yusuf 2006a)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     STEMI:  I.V.: 2.5 mg once; subsequent doses: SubQ: 2.5 mg once daily; treat for up to 8 days or until hospital discharge (Antman, 2007; Yusuf, 2006b)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Note:",
"     </b>",
"     Discontinue fondaparinux 24 hours prior to coronary artery bypass graft (CABG) surgery; instead, administer unfractionated heparin per institutional practice (Anderson, 2007).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Acute symptomatic superficial vein thrombosis (&ge;5 cm in length) of the legs (unlabeled use):",
"     </b>",
"     SubQ: 2.5 mg once daily for 45 days (Decousus, 2010; Guyatt, 2012)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Acute thrombosis (unrelated to HIT) in patients with a past history of HIT (unlabeled use; Guyatt, 2012; Warkentin, 2011):",
"     </b>",
"     SubQ:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &lt;50 kg: 5 mg once daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     50-100 kg: 7.5 mg once daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &gt;100 kg: 10 mg once daily",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F174019\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F174020\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     30-50 mL/minute: Use caution; total clearance ~40% lower compared to patients with normal renal function. When used for thromboprophylaxis, the American College of Chest Physicians suggests a 50% reduction in dose or use of low-dose heparin instead of fondaparinux (Garcia, 2012).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;30 mL/minute: Use is contraindicated.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F9537831\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mild-to-moderate impairment: Dosage adjustment not required; monitor for signs of bleeding.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Severe impairment: No dosage adjustment provided in manufacturer's labeling (has not been studied).",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F173990\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution, as sodium [preservative free]: 2.5 mg/0.5 mL (0.5 mL); 5 mg/0.4 mL (0.4 mL); 7.5 mg/0.6 mL (0.6 mL); 10 mg/0.8 mL (0.8 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Arixtra&reg;: 2.5 mg/0.5 mL (0.5 mL); 5 mg/0.4 mL (0.4 mL); 7.5 mg/0.6 mL (0.6 mL); 10 mg/0.8 mL (0.8 mL)",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F173976\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F173994\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;margin-left:0em;margin-top:0em;display:inline\">",
"     Do",
"     <b>",
"      not",
"     </b>",
"     administer I.M.; intended for SubQ administration. Do not mix with other injections or infusions. Do not expel air bubble from syringe before injection. Administer according to recommended regimen; when used for DVT prophylaxis, early initiation (before 6 hours after orthopedic surgery) has been associated with increased bleeding. For STEMI patients (Canadian labeling; unlabeled use in U.S.) may administer initial dose as I.V. push or mix in 25-50 mL of NS (do not mix with other agents) and infuse over 2 minutes; flush tubing with NS after infusion to ensure complete administration for fondaparinux.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;\">",
"     To convert from I.V. unfractionated heparin (UFH) infusion to SubQ fondaparinux (Nutescu, 2007): Calculate specific dose for fondaparinux based on indication, discontinue UFH, and begin fondaparinux within 1 hour",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     To convert from SubQ fondaparinux to I.V. UFH infusion (Nutescu, 2007): Discontinue fondaparinux; calculate specific dose for I.V. UFH infusion based on indication; omit heparin bolus/loading dose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <i>",
"      For subQ fondaparinux dosed every 24 hours:",
"     </i>",
"     Start I.V. UFH infusion 22-23 hours after last dose of fondaparinux",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F3070645\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Do not mix with other injections or infusions.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Canadian labeling: Stable in NS",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F173993\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Prophylaxis of deep vein thrombosis (DVT) in patients undergoing surgery for hip replacement, knee replacement, hip fracture (including extended prophylaxis following hip fracture surgery), or abdominal surgery (in patients at risk for thromboembolic complications); treatment of acute pulmonary embolism (PE); treatment of acute DVT without PE",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:0em;margin-top:2em;\">",
"     Canadian labeling: Additional uses (not approved in U.S.): Unstable angina or non-ST segment elevation myocardial infarction (UA/NSTEMI) for the prevention of death and subsequent MI; ST segment elevation MI (STEMI) for the prevention of death and myocardial reinfarction",
"    </p>",
"   </div>",
"   <div class=\"block usu drugH1Div\" id=\"F3422521\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use - Unlabeled",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Prophylaxis of DVT in patients with a history of heparin-induced thrombocytopenia (HIT); treatment of acute thrombosis (unrelated to HIT) in patients with a past history of HIT; acute symptomatic superficial vein thrombosis (&ge;5 cm in length) of the legs",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F5174539\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Arixtra&reg; may be confused with Arista&reg; AH (hemostatic device)",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      High alert medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       The Institute for Safe Medication Practices (ISMP) includes this medication among its list of drugs which have a heightened risk of causing significant patient harm when used in error.",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F174032\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     As with all anticoagulants, bleeding is the major adverse effect. Hemorrhage may occur at any site. Risk appears increased by a number of factors including renal dysfunction, age (&gt;75 years), and weight (&lt;50 kg).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &gt;10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Fever (4% to 14%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Nausea (3% to 11%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hematologic: Anemia (1% to 20%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cardiovascular: Edema (9%), hypotension (4%), hypertension (2%), chest pain (1%), thrombosis PCI catheter (without heparin 1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Insomnia (4% to 5%), headache (2% to 5%), dizziness (4%), confusion (3%), pain (2%), anxiety (1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dermatologic: Rash (8%), purpura (4%), bullous eruption (3%), bruising (1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Hypokalemia (1% to 4%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Constipation (5% to 9%), vomiting (1% to 6%), diarrhea (2% to 3%), dyspepsia (2%), abdominal pain (1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Genitourinary: Urinary tract infection (2% to 4%), urinary retention (3%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hematologic: Minor bleeding (2% to 4%), moderate thrombocytopenia (50,000-100,000/mm",
"     <sup>",
"      3",
"     </sup>",
"     : 3%), hematoma (3%), major bleeding (1% to 3%), prothrombin decreased (1%), risk of major bleeding increased as high as 5% in patients receiving initial dose &lt;6 hours following surgery",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hepatic: ALT increased (&le;3%), AST increased (&le;2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Local: Injection site reaction (bleeding, rash, pruritus)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Back pain (1%), leg pain (1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Cough (2%), pneumonia (2%), epistaxis (1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Miscellaneous: Wound drainage increased (5%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &lt;1% (Limited to important or life-threatening): aPTT increased (associated with bleeding), heparin-induced thrombocytopenia (1 case report), hepatic dysfunction, severe thrombocytopenia (&lt;50,000/mm",
"     <sup>",
"      3",
"     </sup>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F173997\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to fondaparinux or any component of the formulation; severe renal impairment (Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;30 mL/minute); body weight &lt;50 kg (prophylaxis); active major bleeding; bacterial endocarditis; thrombocytopenia associated with a positive",
"     <i>",
"      in vitro",
"     </i>",
"     test for antiplatelet antibody in the presence of fondaparinux",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F173979\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Bleeding: Monitor patient closely for signs or symptoms of bleeding. Certain patients are at increased risk of bleeding. Risk factors include bacterial endocarditis; congenital or acquired bleeding disorders; active ulcerative or angiodysplastic GI diseases; severe uncontrolled hypertension; hemorrhagic stroke; or use shortly after brain, spinal, or ophthalmology surgery; in patients treated concomitantly with platelet inhibitors; recent GI bleeding; thrombocytopenia or platelet defects; renal impairment; hepatic impairment; hypertensive or diabetic retinopathy; or in patients undergoing invasive procedures. Risk of major bleeding may be increased if initial dose is administered earlier than recommended (initiation recommended at 6-8 hours following surgery). Do not administer with other agents that increase the risk of hemorrhage unless they are essential for the management of the underlying condition (eg, warfarin for treatment of VTE). Although considered an insensitive measure of fondaparinux activity, there have been postmarketing reports of bleeding associated with elevated aPTT. Discontinue if bleeding occurs.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Thrombocytopenia: Has occurred with administration, including very rare reports of thrombocytopenia with thrombosis similar to heparin-induced thrombocytopenia (HIT); however, has been used in patients with current or history of HIT due to a lack of an immune-mediated effect on platelets (Guyatt [ACCP], 2012; Savi, 2005). Use is contraindicated in patients with thrombocytopenia associated with a positive",
"     <i>",
"      in vitro",
"     </i>",
"     test for antiplatelet antibodies in the presence of fondaparinux. Monitor patients closely and discontinue therapy if platelets fall to &lt;100,000/mm",
"     <sup>",
"      3",
"     </sup>",
"     and/or thrombosis develops.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Use with caution in patients with moderate renal dysfunction (Cl",
"     <sub>",
"      cr",
"     </sub>",
"     30-50 mL/minute); contraindicated in patients with Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;30 mL/minute. Periodically monitor renal function; discontinue if severe dysfunction or labile function develops.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Elderly: Use with caution in the elderly; elimination half-life prolonged in patients &gt;75 years of age.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Patients &lt;50 kg: Use with caution in patients &lt;50 kg who are being treated for DVT/PE; fondaparinux clearance may be decreased, increasing the risk for bleeding; dosage reduction recommended. Contraindicated in patients &lt;50 kg when used for prophylactic therapy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Dosage form specific issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Latex: The needle guard contains natural latex rubber.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Appropriate use: For subcutaneous administration; not for I.M. administration. Do not use interchangeably (unit for unit) with low molecular weight heparins, heparin, or heparinoids.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Appropriate use: Surgical patients: Discontinue use 24 hours prior to CABG and dose with unfractionated heparin per institutional practice (Jneid, 2012).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Neuraxial anesthesia:",
"     <b>",
"      [U.S. Boxed Warning]: Spinal or epidural hematomas, including subsequent paralysis, may occur with recent or anticipated neuraxial anesthesia (epidural or spinal anesthesia) or spinal puncture in patients anticoagulated with LMWH, heparinoids, or fondaparinux.",
"     </b>",
"     Consider risk versus benefit prior to spinal procedures; risk is increased by the use of concomitant agents which may alter hemostasis, the use of indwelling epidural catheters for analgesia, a history of spinal deformity or spinal surgery, as well as a history of traumatic or repeated epidural or spinal punctures. Patient should be observed closely for bleeding and signs and symptoms of neurological impairment if therapy is administered during or immediately following diagnostic lumbar puncture, epidural anesthesia, or spinal anesthesia.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Percutaneous coronary intervention (PCI): The administration of fondaparinux as the sole anticoagulant is",
"     <b>",
"      not recommended",
"     </b>",
"     during PCI due to an increased risk for guiding-catheter thrombosis. Use of an anticoagulant with antithrombin activity (eg, unfractionated heparin) is recommended as adjunctive therapy to PCI even if prior treatment with fondaparinux (must take into account whether GP IIb/IIIa antagonists have been administered) (Levine, 2011).",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299363\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F173983\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Agents with Antiplatelet Properties (e.g., P2Y12 inhibitors, NSAIDs, SSRIs, etc.): May enhance the anticoagulant effect of Anticoagulants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anticoagulants: May enhance the anticoagulant effect of other Anticoagulants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Apixaban: May enhance the anticoagulant effect of Anticoagulants.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Collagenase (Systemic): Anticoagulants may enhance the adverse/toxic effect of Collagenase (Systemic). Specifically, the risk of injection site bruising and/or bleeding may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dabigatran Etexilate: May enhance the anticoagulant effect of Anticoagulants.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dasatinib: May enhance the anticoagulant effect of Anticoagulants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferasirox: Anticoagulants may enhance the adverse/toxic effect of Deferasirox. Specifically, the risk for GI ulceration/irritation or GI bleeding may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Drotrecogin Alfa (Activated): May enhance the adverse/toxic effect of Fondaparinux. Bleeding may occur. Management: Monitor for increased risk of bleeding during concomitant therapy. Consider avoiding concomitant use, when possible.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herbs (Anticoagulant/Antiplatelet Properties) (eg, Alfalfa, Anise, Bilberry): May enhance the adverse/toxic effect of Anticoagulants. Bleeding may occur.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ibritumomab: Anticoagulants may enhance the adverse/toxic effect of Ibritumomab. Both agents may contribute to an increased risk of bleeding.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Nonsteroidal Anti-Inflammatory Agents: May enhance the anticoagulant effect of Anticoagulants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Omacetaxine: Anticoagulants may enhance the adverse/toxic effect of Omacetaxine. Specifically, the risk for bleeding-related events may be increased.  Management: Avoid concurrent use of anticoagulants with omacetaxine in patients with a platelet count of less than 50,000/uL.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Omega-3 Fatty Acids: May enhance the anticoagulant effect of Anticoagulants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pentosan Polysulfate Sodium: May enhance the anticoagulant effect of Anticoagulants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Prostacyclin Analogues: May enhance the adverse/toxic effect of Anticoagulants. Specifically, the antiplatelet effects of these agents may lead to an increased risk of bleeding with the combination.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rivaroxaban: Anticoagulants may enhance the anticoagulant effect of Rivaroxaban.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Salicylates: May enhance the anticoagulant effect of Anticoagulants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thrombolytic Agents: May enhance the anticoagulant effect of Anticoagulants. Management: See full drug monograph for guidelines for the use of alteplase for acute ischemic stroke during treatment with oral anticoagulants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tipranavir: May enhance the anticoagulant effect of Anticoagulants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tositumomab and Iodine I 131 Tositumomab: Anticoagulants may enhance the adverse/toxic effect of Tositumomab and Iodine I 131 Tositumomab. Specifically, the risk of bleeding-related adverse effects may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin E: May enhance the anticoagulant effect of Anticoagulants. Vitamin E may also increase the overall risk for bleeding.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F174010\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Herb/Nutraceutical: Avoid alfalfa, anise, bilberry, bladderwrack, bromelain, cat's claw, celery, coleus, cordyceps, dong quai, evening primrose oil, fenugreek, feverfew, garlic, ginger, ginkgo biloba, ginseng (American/Panax/Siberian), grapeseed, green tea, guggul, horse chestnut seed, horseradish, licorice, prickly ash, red clover, reishi, sweet clover, turmeric, white willow (all possess anticoagulant or antiplatelet activity and as such, may enhance the anticoagulant effects of fondaparinux).",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F173986\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F173999\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse events were not observed in animal reproduction studies. Based on case reports, small amounts of fondaparinux have been detected in the umbilical cord following multiple doses during pregnancy (Dempfle, 2004). Use of fondaparinux in pregnancy should be limited to those women who have severe allergic reactions to heparin, including heparin-induced thrombocytopenia, and who cannot receive danaparoid (Guyatt, 2012).",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F174023\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/use caution",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F14050079\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Fondaparinux is not recommended for use in breast-feeding women; use of alternative anticoagulants is preferred.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F3422230\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Arixtra Subcutaneous)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     2.5 mg/0.5 mL (0.5 mL): $63.76",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     5 mg/0.4 mL (0.4 mL): $150.06",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     7.5 mg/0.6 mL (0.6 mL): $150.06",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10 mg/0.8 mL (0.8 mL): $142.90",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Fondaparinux Sodium Subcutaneous)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     2.5 mg/0.5 mL (0.5 mL): $57.70",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     5 mg/0.4 mL (0.4 mL): $135.80",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     7.5 mg/0.6 mL (0.6 mL): $135.80",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10 mg/0.8 mL (0.8 mL): $135.80",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F173988\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Periodic monitoring of CBC, platelet count, serum creatinine, occult blood testing of stools recommended. Anti-Xa activity of fondaparinux can be measured by the assay if fondaparinux is used as the calibrator. PT and aPTT are insensitive measures of fondaparinux activity. If unexpected changes in coagulation parameters or major bleeding occur, discontinue fondaparinux (elevated aPTT associated with bleeding events have been reported in postmarketing data).",
"    </p>",
"   </div>",
"   <div class=\"block rer drugH1Div\" id=\"F14050080\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reference Range",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Routine monitoring is not recommended; the following fondaparinux-specific anti-Xa concentrations have been reported (Garcia, 2012):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thromboprophylaxis dose: Anti-Xa activity at 3 hours post dose: ~ 0.39-0.5 mg/L",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Therapeutic dosing (eg, 7.5 mg once daily): Anti-Xa activity at 3 hours post dose: 1.2-1.26 mg/L",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F174000\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Arixtra (AR, AT, AU, BB, BE, BG, BM, BR, BS, BZ, CH, CL, CN, CO, CR, CZ, DE, DK, DO, EC, EE, FI, FR, GB, GR, GT, GY, HN, ID, IE, IL, IN, IT, JM, KP, MT, MX, MY, NI, NL, NO, PA, PE, PH, PL, PR, PT, RU, SE, SG, SK, SR, SV, TH, TR, TT, TW, UY);",
"     </li>",
"     <li>",
"      Quixidar (AT, BE, BG, CH, CZ, DE, DK, EE, FR, GB, IE, IT, MT, NL, NO, PL, RU, SE, SK, TR)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F173978\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Fondaparinux is a synthetic pentasaccharide that causes an antithrombin III-mediated selective inhibition of factor Xa. Neutralization of factor Xa interrupts the blood coagulation cascade and inhibits thrombin formation and thrombus development.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F173996\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: SubQ: Rapid and complete",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: V",
"     <sub>",
"      d",
"     </sub>",
"     : 7-11 L; mainly in blood",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: &ge;94% to antithrombin III",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Bioavailability: SubQ: 100%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: 17-21 hours; prolonged with renal impairment",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak: SubQ: 2-3 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Urine (~77%, unchanged drug)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Anderson JL, Adams CD, Antman EM, et al, &ldquo;ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction: Executive Summary. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients with Unstable Angina/Non ST-Elevation Myocardial Infarction) Developed in Collaboration With the American College of Emergency Physicians, The Society of Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons,&rdquo;",
"      <i>",
"       Circulation",
"      </i>",
"      , 2007, 116(7):e148-304.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/35/40503/abstract-text/17679616/pubmed\" id=\"17679616\" target=\"_blank\">",
"        17679616",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Antman EM, Anbe DT, Armstrong PW, et al, &ldquo;ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction),&rdquo;",
"      <i>",
"       Circulation",
"      </i>",
"      , 2004, 110(9):e82-292.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/35/40503/abstract-text/15339869/pubmed\" id=\"15339869\" target=\"_blank\">",
"        15339869",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Antman EM, Hand M, Armstrong PW, et al, &ldquo;2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines,&rdquo;",
"      <i>",
"       J Am Coll Cardiol",
"      </i>",
"      , 2008, 51(2):210-49.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/35/40503/abstract-text/18191746/pubmed\" id=\"18191746\" target=\"_blank\">",
"        18191746",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Bauer KA, Eriksson BI, Lassen MR, et al, &ldquo;Fondaparinux Compared With Enoxaparin for the Prevention of Venous Thromboembolism After Elective Major Knee Surgery,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2001, 345:1305-10.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/35/40503/abstract-text/11794149/pubmed\" id=\"11794149\" target=\"_blank\">",
"        11794149",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Bauer KA, &ldquo;Fondaparinux Sodium: A Selective Inhibitor of Factor Xa,&rdquo;",
"      <i>",
"       Am J Health Syst Pharm",
"      </i>",
"      , 2001, 58(Suppl 2):14-7.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Blackmer AB, Oertel MD, and Valgus JM, &ldquo;Fondaparinux and the Management of Heparin-induced Thrombocytopenia: The Journey Continues,&rdquo;",
"      <i>",
"       Ann Pharmacother",
"      </i>",
"      , 2009, 43(!0):1636-46.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/35/40503/abstract-text/19737996/pubmed\" id=\"19737996\" target=\"_blank\">",
"        19737996",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Buller HR, Davidson BL, Decousus H, et al, &ldquo;Fondaparinux or Enoxaparin for the Initial Treatment of Symptomatic Deep Venous Thrombosis: A Randomized Trial,&rdquo;",
"      <i>",
"       Ann Intern Med",
"      </i>",
"      , 2004, 140(11):867-73.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/35/40503/abstract-text/15172900/pubmed\" id=\"15172900\" target=\"_blank\">",
"        15172900",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Buller HR, Davidson BL, Decousus H, et al, &ldquo;Subcutaneous Fondaparinux Versus Intravenous Unfractionated Heparin in the Initial Treatment of Pulmonary Embolism,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2003, 349(18):1695-702.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/35/40503/abstract-text/14585937/pubmed\" id=\"14585937\" target=\"_blank\">",
"        14585937",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Decousus H, Prandoni P, Mismetti P, et al, &ldquo;Fondaparinux for the Treatment of Superficial-Vein Thrombosis in the Legs,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2010, 363(13):1222-32.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/35/40503/abstract-text/20860504/pubmed\" id=\"20860504\" target=\"_blank\">",
"        20860504",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Dempfle CE, &ldquo;Minor Transplacental Passage of Fondaparinux",
"      <i>",
"       in vivo",
"      </i>",
"      ,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2004, 350(18):1914-5.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/35/40503/abstract-text/15115845/pubmed\" id=\"15115845\" target=\"_blank\">",
"        15115845",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Eriksson BI, Bauer KA, Lassen MR, et al, &ldquo;Fondaparinux Compared With Enoxaparin for the Prevention of Venous Thromboembolism After Hip-Fracture Surgery,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2001, 345:1298-304.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/35/40503/abstract-text/11794148/pubmed\" id=\"11794148\" target=\"_blank\">",
"        11794148",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Garcia DA, Baglin TP, Weitz JI, et al, &ldquo;Parenteral Anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines,&rdquo;",
"      <i>",
"       Chest",
"      </i>",
"      , 2012, 141(2 Suppl):24-43.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/35/40503/abstract-text/22315264/pubmed\" id=\"22315264\" target=\"_blank\">",
"        22315264",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Guyatt GH, Akl EA, Crowther M, et al, &ldquo;Executive Summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines,&rdquo;",
"      <i>",
"       Chest",
"      </i>",
"      , 2012, 141(2 Suppl):7-47.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/35/40503/abstract-text/22315257/pubmed\" id=\"22315257\" target=\"_blank\">",
"        22315257",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Harenberg J, Jorg I, and Fenyvesi T, &ldquo;Treatment of Heparin-induced Thrombocytopenia With Fondaparinux,&rdquo;",
"      <i>",
"       Haematologica",
"      </i>",
"      , 2004, 89(8):1017-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/35/40503/abstract-text/15339691/pubmed\" id=\"15339691\" target=\"_blank\">",
"        15339691",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Jneid H, Anderson JL, Wright RS, et al, &ldquo;2012 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction (Updating the 2007 Guideline and Replacing the 2011 Focused Update): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines,&rdquo;",
"      <i>",
"       Circulation",
"      </i>",
"      , 2012, 126(7):875-910.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/35/40503/abstract-text/22800849/pubmed\" id=\"22800849\" target=\"_blank\">",
"        22800849",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Levine GN, Bates ER, Blankenship JC, et al, &ldquo;2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions,&rdquo;",
"      <i>",
"       Circulation",
"      </i>",
"      , 2011, 124(23):e574-651.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/35/40503/abstract-text/22064601/pubmed\" id=\"22064601\" target=\"_blank\">",
"        22064601",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Nutescu EA and Dager W, &ldquo;Heparin, Low Molecular Weight Heparin, and Fondaparinux,&rdquo;",
"      <i>",
"       Managing Anticoagulation Patients in the Hospital",
"      </i>",
"      , Gulseth M ed, American Society of Health-System Pharmacists&reg;, Bethesda, MD: 2007, 181.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      O'Gara PT, Kushner FG, Ascheim DD, et al, \"2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines,\"",
"      <i>",
"       Circulation",
"      </i>",
"      , 2012, 127(4):e362-425.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/35/40503/abstract-text/3247304/pubmed\" id=\"3247304\" target=\"_blank\">",
"        3247304",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Parody R, Oliver A, Souto JC, et al, &ldquo;Fondaparinux (Arixtra&reg;), as an Alternative Antithrombotic Prophylaxis When There is Hypersensitivity to Low Molecular Weight and Unfractionated Heparins,&rdquo;",
"      <i>",
"       Haematologica",
"      </i>",
"      , 2007, 88(11):ECR32.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/35/40503/abstract-text/14607764/pubmed\" id=\"14607764\" target=\"_blank\">",
"        14607764",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Savi P, Chong BH, Greinacher A, et al, &ldquo;Effect of Fondaparinux on Platelet Activation in the Presence of Heparin-Dependent Antibodies: A Blinded Comparative Multicenter Study With Unfractionated Heparin,&rdquo;",
"      <i>",
"       Blood",
"      </i>",
"      , 2005, 105(1):139-44.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/35/40503/abstract-text/15388575/pubmed\" id=\"15388575\" target=\"_blank\">",
"        15388575",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Warkentin TE, Davidson BL, Buller HR, et al, &ldquo;Prevalence and Risk of Preexisting Heparin-Induced Thrombocytopenia Antibodies in Patients With Acute VTE,&rdquo;",
"      <i>",
"       Chest",
"      </i>",
"      , 2011, 140(2):366-73.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/35/40503/abstract-text/21393394/pubmed\" id=\"21393394\" target=\"_blank\">",
"        21393394",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Warkentin TE, Maurer BT, and Aster RH, &ldquo;Heparin-Induced Thrombocytopenia Associated With Fondaparinux,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2007, 356(25):2653-55.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/35/40503/abstract-text/17582083/pubmed\" id=\"17582083\" target=\"_blank\">",
"        17582083",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Yusuf S, Mehta SR, Chrolavicius S, et al, &ldquo;Comparison of Fondaparinux and Enoxaparin in Acute Coronary Syndromes &minus; The Fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2006a, 354(14):1464-76.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/35/40503/abstract-text/16537663/pubmed\" id=\"16537663\" target=\"_blank\">",
"        16537663",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Yusuf S, Mehta SR, Chrolavicius S, et al, &ldquo;Effects of Fondaparinux on Mortality and Reinfarction in Patients With Acute ST-Segment Elevation Myocardial Infarction: The OASIS-6 Randomized Trial,&rdquo;",
"      <i>",
"       JAMA",
"      </i>",
"      , 2006b, 295(13):1519-30.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/35/40503/abstract-text/16537725/pubmed\" id=\"16537725\" target=\"_blank\">",
"        16537725",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8691 Version 49.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.248-AB4CE9AEE9-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_35_40503=[""].join("\n");
var outline_f39_35_40503=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5708809\">",
"      ALERT: U.S. Boxed Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F174015\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F174016\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F174034\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F174018\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F174019\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F174020\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9537831\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F173990\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F173976\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F173994\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3070645\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F173993\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3422521\">",
"      Use - Unlabeled",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5174539\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F174032\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F173997\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F173979\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299363\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F173983\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F174010\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F173986\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F173999\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F174023\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14050079\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3422230\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F173988\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14050080\">",
"      Reference Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F174000\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F173978\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F173996\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8691\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8691|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?37/8/38020?source=related_link\">",
"      Fondaparinux: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f39_35_40504="Pyogenic granuloma histology 2";
var content_f39_35_40504=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F50978&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F50978&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Pyogenic granuloma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Pyogenic granuloma from the neck of a 4-year-old boy. At higher power, the lesion consists of condensed small-caliber vessels with scattered red blood cells. The stroma is fibromyxoid with scattered inflammatory cells. Cytologic atypia and mitoses are not present, but can be seen.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Copyright &copy; Greg Hosler, MD, PhD, Dermatlas;",
"     <a href=\"file://www.dermatlas.org\" target=\"_blank\">",
"      file://www.dermatlas.org",
"     </a>",
"     .",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_35_40504=[""].join("\n");
var outline_f39_35_40504=null;
var title_f39_35_40505="Use of vasopressors and inotropes";
var content_f39_35_40505=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Use of vasopressors and inotropes",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/35/40505/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/35/40505/contributors\">",
"     Scott Manaker, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/35/40505/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/35/40505/contributors\">",
"     Polly E Parsons, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/35/40505/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/35/40505/contributors\">",
"     Geraldine Finlay, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?39/35/40505/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 21, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vasopressors are a powerful class of drugs that induce vasoconstriction and thereby elevate mean arterial pressure (MAP). Vasopressors differ from inotropes, which increase cardiac contractility; however, many drugs have both vasopressor and inotropic effects. Although many vasopressors have been used since the 1940s, few controlled clinical trials have directly compared these agents or documented improved outcomes due to their use [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/35/40505/abstract/1\">",
"     1",
"    </a>",
"    ]. Thus, the manner in which these agents are commonly used largely reflects expert opinion, animal data, and the use of surrogate end points such as tissue oxygenation as a proxy for decreased morbidity and mortality.",
"   </p>",
"   <p>",
"    Basic adrenergic receptor physiology and the principles, complications, and controversies surrounding use of vasopressors and inotropes for treatment of shock are presented here. Issues related to the differential diagnosis of shock and the use of vasopressors in patients with septic shock are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/62/6120?source=see_link\">",
"     \"Shock in adults: Types, presentation, and diagnostic approach\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/51/21306?source=see_link\">",
"     \"Evaluation and management of severe sepsis and septic shock in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     RECEPTOR PHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The main categories of adrenergic receptors relevant to vasopressor activity are the alpha-1, beta-1, and beta-2 adrenergic receptors, as well as the",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?41/20/42310?source=see_link\">",
"     dopamine",
"    </a>",
"    receptors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/35/40505/abstract/2,3\">",
"     2,3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Alpha adrenergic",
"    </span>",
"    &nbsp;&mdash;&nbsp;Activation of alpha-1 adrenergic receptors, located in vascular walls, induces significant vasoconstriction. Alpha-1 adrenergic receptors are also present in the heart and can increase the duration of contraction without increased chronotropy. However, clinical significance of this phenomenon is unclear [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/35/40505/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Beta adrenergic",
"    </span>",
"    &nbsp;&mdash;&nbsp;Beta-1 adrenergic receptors are most common in the heart, and mediate increases in inotropy and chronotropy with minimal vasoconstriction. Stimulation of beta-2 adrenergic receptors in blood vessels induces vasodilation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Dopamine",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?41/20/42310?source=see_link\">",
"     Dopamine",
"    </a>",
"    receptors are present in the renal, splanchnic (mesenteric), coronary, and cerebral vascular beds; stimulation of these receptors leads to vasodilation. A second subtype of dopamine receptors causes vasoconstriction by inducing",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?16/28/16838?source=see_link\">",
"     norepinephrine",
"    </a>",
"    release.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     PRINCIPLES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypotension may result from hypovolemia (eg, exsanguination), pump failure (eg, severe medically refractory heart failure or shock complicating myocardial infarction), or a pathologic maldistribution of blood flow (eg, septic shock, anaphylaxis). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/62/6120?source=see_link\">",
"     \"Shock in adults: Types, presentation, and diagnostic approach\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/37/7769?source=see_link\">",
"     \"Inotropic agents in heart failure due to systolic dysfunction\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Vasopressors are indicated for a decrease of &gt;30 mmHg from baseline systolic blood pressure, or a mean arterial pressure &lt;60 mmHg when either condition results in end-organ dysfunction due to hypoperfusion. Hypovolemia should be corrected prior to the institution of vasopressor therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/35/40505/abstract/5\">",
"     5",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/20/13639?source=see_link\">",
"     \"Treatment of severe hypovolemia or hypovolemic shock in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The rational use of vasopressors and inotropes is guided by three fundamental concepts:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One drug, many receptors &ndash; A given drug often has multiple effects because of actions upon more than one receptor. As an example,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/57/25494?source=see_link\">",
"       dobutamine",
"      </a>",
"      increases cardiac output by beta-1 adrenergic receptor activation; however, it also acts upon beta-2 adrenergic receptors and thus induces vasodilation and can cause hypotension.",
"     </li>",
"     <li>",
"      Dose-response curve &ndash; Many agents have dose-response curves, such that the primary adrenergic receptor subtype activated by the drug is dose-dependent. As an example,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?41/20/42310?source=see_link\">",
"       dopamine",
"      </a>",
"      stimulates beta-1 adrenergic receptors at doses of 2 to 10",
"      <span class=\"nowrap\">",
"       mcg/kg",
"      </span>",
"      per minute, and alpha adrenergic receptors when doses exceed 10",
"      <span class=\"nowrap\">",
"       mcg/kg",
"      </span>",
"      per minute.",
"     </li>",
"     <li>",
"      Direct versus reflex actions &ndash; A given agent can affect MAP both by direct actions on adrenergic receptors and by reflex actions triggered by the pharmacologic response.",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?16/28/16838?source=see_link\">",
"       Norepinephrine",
"      </a>",
"      -induced beta-1 adrenergic stimulation alone normally would cause tachycardia. However, the elevated MAP from norepinephrine's alpha-adrenergic receptor-induced vasoconstriction results in a reflex decrease in heart rate. The net result may be a stable or slightly reduced heart rate when the drug is used.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     PRACTICAL ISSUES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Use of vasopressors and inotropic agents requires attention to a number of issues:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Volume resuscitation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Repletion of adequate intravascular volume, when time permits, is crucial prior to the initiation of vasopressors. As an example, most patients with septic shock require at least 2 liters of intravenous fluid in order for vasopressors to be maximally effective [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/35/40505/abstract/6\">",
"     6",
"    </a>",
"    ]. Vasopressors will be ineffective or only partially effective in the setting of coexistent hypovolemia.",
"   </p>",
"   <p>",
"    Fluids may be withheld in patients with significant pulmonary edema due to the acute respiratory distress syndrome (ARDS) or heart failure (HF). In patients with a pulmonary artery catheter, pulmonary capillary wedge pressures (PCWP) of 18 to 24 mmHg are recommended for cardiogenic shock [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/35/40505/abstract/7\">",
"     7",
"    </a>",
"    ], and 12 to 14 mmHg for septic or hypovolemic shock [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/35/40505/abstract/8\">",
"     8",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/10/44199?source=see_link\">",
"     \"Pulmonary artery catheterization: Interpretation of tracings\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Selection and titration",
"    </span>",
"    &nbsp;&mdash;&nbsp;Choice of an initial agent should be based upon the suspected underlying etiology of shock (eg,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/57/25494?source=see_link\">",
"     dobutamine",
"    </a>",
"    in cases of cardiac failure without significant hypotension). The dose should be titrated up to achieve effective blood pressure or end-organ perfusion as evidenced by such criteria as urine output or mentation. If maximal doses of a first agent are inadequate, then a second drug should be added to the first. In situations where this is ineffective, such as refractory septic shock, anecdotal reports describe adding a third agent, although no controlled trials have demonstrated the utility of this approach.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Route of administration",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vasopressors and inotropic agents should be administered through an appropriately positioned central venous catheter, if available. This facilitates more rapid delivery of the agent to the heart for systemic distribution and eliminates the risk of peripheral extravasation. When a patient does not have a central venous catheter, vasopressors and inotropic agents can be administered through an appropriately positioned peripheral intravenous catheter temporarily, until a central venous catheter is inserted. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/1/29?source=see_link\">",
"     \"Complications of central venous catheters and their prevention\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/32/44553?source=see_link\">",
"     \"Overview of central venous access\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Tachyphylaxis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Responsiveness to these drugs can decrease over time due to tachyphylaxis. Doses must be constantly titrated to adjust for this phenomenon and for changes in the patient's clinical condition [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/35/40505/abstract/9,10\">",
"     9,10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Hemodynamic effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;MAP is influenced by systemic vascular resistance (SVR) and cardiac output (CO). In situations such as cardiogenic shock, elevating SVR increases afterload and the work of an already failing heart, thus potentially lowering CO. Some authors recommend keeping the SVR approximately 700 to 1000 dynes x",
"    <span class=\"nowrap\">",
"     sec/cm",
"     <sup>",
"      5",
"     </sup>",
"    </span>",
"    to avoid excessive afterload and to minimize complications from profound vasoconstriction (",
"    <a class=\"calc calc_professional\" href=\"mobipreview.htm?25/56/26497?source=see_link\">",
"     calculator 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/35/40505/abstract/11\">",
"     11",
"    </a>",
"    ]. However, there is no consensus regarding an ideal target cardiac index (CI). Studies that have attempted to maintain a supraphysiologic CI of &gt;4.0 to 4.5",
"    <span class=\"nowrap\">",
"     L/minute",
"    </span>",
"    per m",
"    <sup>",
"     2",
"    </sup>",
"    have not shown consistent benefit [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/35/40505/abstract/12,13\">",
"     12,13",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/44/31430?source=see_link\">",
"     \"Oxygen delivery and consumption\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Subcutaneous delivery of medications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Critically ill patients often receive subcutaneously injected medications, such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    and insulin. The bioavailability of these medications can be reduced during treatment with vasopressors due to cutaneous vasoconstriction.",
"   </p>",
"   <p>",
"    This was demonstrated in a study that monitored plasma factor Xa levels in three groups of hospitalized patients following the initiation of prophylactic low molecular weight",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/35/40505/abstract/14\">",
"     14",
"    </a>",
"    ]. Patients who required vasopressor support (",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?41/20/42310?source=see_link\">",
"     dopamine",
"    </a>",
"    &gt;10",
"    <span class=\"nowrap\">",
"     &micro;g/kg",
"    </span>",
"    per minute,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?16/28/16838?source=see_link\">",
"     norepinephrine",
"    </a>",
"    &gt;0.25",
"    <span class=\"nowrap\">",
"     &micro;g/kg",
"    </span>",
"    per minute, or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/36/39488?source=see_link\">",
"     phenylephrine",
"    </a>",
"    &gt;2",
"    <span class=\"nowrap\">",
"     &micro;g/kg",
"    </span>",
"    per minute) had decreased factor Xa activity compared to both ICU patients who did not require vasopressors and routine postoperative control patients. The clinical significance of the decrease in plasma factor Xa levels was not determined.",
"   </p>",
"   <p>",
"    The authors of the study suggested that patients might need higher doses of LMW",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    to attain adequate thrombosis prophylaxis. Another approach is to change subcutaneous medications to an intravenous form whenever a patient is receiving vasopressor therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Frequent reevaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Critically ill patients may undergo a second hemodynamic insult which necessitates a change in vasopressor or inotrope management. The dosage of a given agent should not simply be increased because of persistent or worsening hypotension without reconsideration of the patient's clinical situation and the appropriateness of the current strategy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     ADRENERGIC AGENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adrenergic agents, such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/36/39488?source=see_link\">",
"     phenylephrine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?16/28/16838?source=see_link\">",
"     norepinephrine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?41/20/42310?source=see_link\">",
"     dopamine",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/57/25494?source=see_link\">",
"     dobutamine",
"    </a>",
"    , are the most commonly used vasopressor and inotropic drugs in critically ill patients. These agents manifest different receptor selectivity and clinical effects (",
"    <a class=\"graphic graphic_table graphicRef63100 \" href=\"mobipreview.htm?32/5/32860\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H376789843\">",
"    <span class=\"h2\">",
"     Norepinephrine",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?16/28/16838?source=see_link\">",
"     Norepinephrine",
"    </a>",
"    (Levophed) acts on both alpha-1 and beta-1 adrenergic receptors, thus producing potent vasoconstriction as well as a modest increase in cardiac output [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/35/40505/abstract/5\">",
"     5",
"    </a>",
"    ]. A reflex bradycardia usually occurs in response to the increased MAP, such that the mild chronotropic effect is canceled out and the heart rate remains unchanged or even decreases slightly. Norepinephrine is the preferred vasopressor for the treatment of septic shock. (See",
"    <a class=\"local\" href=\"#H35\">",
"     'Choice of agent in septic shock'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/51/21306?source=see_link\">",
"     \"Evaluation and management of severe sepsis and septic shock in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Phenylephrine",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/36/39488?source=see_link\">",
"     Phenylephrine",
"    </a>",
"    (Neo-Synephrine) has purely alpha-adrenergic agonist activity and therefore results in vasoconstriction with minimal cardiac inotropy or chronotropy. MAP is augmented by raising SVR [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/35/40505/abstract/15\">",
"     15",
"    </a>",
"    ]. The drug is useful in the setting of hypotension with an SVR &lt;700 dynes x",
"    <span class=\"nowrap\">",
"     sec/cm",
"     <sup>",
"      5",
"     </sup>",
"    </span>",
"    (eg, hyperdynamic sepsis, neurologic disorders, anesthesia-induced hypotension). A potential disadvantage of phenylephrine is that it may decrease stroke volume, so it is reserved for patients in whom",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?16/28/16838?source=see_link\">",
"     norepinephrine",
"    </a>",
"    is contraindicated due to arrhythmias or who have failed other therapies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/35/40505/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although SVR elevation increases cardiac afterload, most studies document that CO is either maintained or actually increased among patients without preexisting cardiac dysfunction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/35/40505/abstract/4,17\">",
"     4,17",
"    </a>",
"    ]. The drug is contraindicated if the SVR is &gt;1200 dynes x",
"    <span class=\"nowrap\">",
"     sec/cm",
"     <sup>",
"      5",
"     </sup>",
"     .",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Epinephrine",
"    </span>",
"    &nbsp;&mdash;&nbsp;Epinephrine (Adrenalin) has potent beta-1 adrenergic receptor activity and moderate beta-2 and alpha-1 adrenergic receptor effects. Clinically, low doses of epinephrine increase CO because of the beta-1 adrenergic receptor inotropic and chronotropic effects, while the alpha adrenergic receptor-induced vasoconstriction is often offset by the beta-2 adrenergic receptor vasodilation. The result is an increased CO, with decreased SVR and variable effects on the MAP [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/35/40505/abstract/3\">",
"     3",
"    </a>",
"    ].However, at higher epinephrine doses the alpha-adrenergic receptor effect predominates, producing increased SVR in addition to an increased CO. Epinephrine is most often used for the treatment of anaphylaxis, as a second line agent (after",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?16/28/16838?source=see_link\">",
"     norepinephrine",
"    </a>",
"    ) in septic shock, and for management of hypotension following coronary artery bypass grafting.",
"   </p>",
"   <p>",
"    Other disadvantages of epinephrine include dysrhythmias (due to beta-1 adrenergic receptor stimulation) and splanchnic vasoconstriction. The degree of splanchnic vasoconstriction appears to be greater with epinephrine than with equipotent doses of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?16/28/16838?source=see_link\">",
"     norepinephrine",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?41/20/42310?source=see_link\">",
"     dopamine",
"    </a>",
"    in patients with severe shock [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/35/40505/abstract/18\">",
"     18",
"    </a>",
"    ], although the clinical importance of this is unclear [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/35/40505/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Ephedrine",
"    </span>",
"    &nbsp;&mdash;&nbsp;Similar to epinephrine, ephedrine acts primarily on alpha- and beta-adrenergic receptors, but with less potency. It also has an effect by leading to release of endogenous",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?16/28/16838?source=see_link\">",
"     norepinephrine",
"    </a>",
"    . Ephedrine is rarely used except in the setting of post-anesthesia-induced hypotension.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Dopamine",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?41/20/42310?source=see_link\">",
"     Dopamine",
"    </a>",
"    (Intropin) has a variety of effects depending upon the dose range administered. It is most often used as a second-line alternative to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?16/28/16838?source=see_link\">",
"     norepinephrine",
"    </a>",
"    in patients with absolute or relative bradycardia and a low risk of tachyarrhythmias. Weight-based administration of dopamine can achieve quite different serum drug concentrations in different individuals [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/35/40505/abstract/19\">",
"     19",
"    </a>",
"    ], but the following provides an approximate description of effects:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      At doses of 1 to 2",
"      <span class=\"nowrap\">",
"       mcg/kg",
"      </span>",
"      per minute,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?41/20/42310?source=see_link\">",
"       dopamine",
"      </a>",
"      acts predominantly on dopamine-1 receptors in the renal, mesenteric, cerebral, and coronary beds, resulting in selective vasodilation. Some reports suggest that dopamine increases urine output by augmenting renal blood flow and glomerular filtration rate, and natriuresis by inhibiting aldosterone and renal tubular sodium transport [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/35/40505/abstract/20-22\">",
"       20-22",
"      </a>",
"      ]. These effects may be blunted by",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/50/32553?source=see_link\">",
"       haloperidol",
"      </a>",
"      and other butyrophenones [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/35/40505/abstract/22\">",
"       22",
"      </a>",
"      ]. However, the clinical significance of these phenomena is unclear, and some patients may develop hypotension at these low doses [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/35/40505/abstract/23\">",
"       23",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?43/25/44435?source=see_link\">",
"       \"Renal actions of dopamine\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      At 5 to 10",
"      <span class=\"nowrap\">",
"       mcg/kg",
"      </span>",
"      per minute,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?41/20/42310?source=see_link\">",
"       dopamine",
"      </a>",
"      also stimulates beta-1 adrenergic receptors and increases cardiac output, predominantly by increasing stroke volume with variable effects on heart rate [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/35/40505/abstract/24\">",
"       24",
"      </a>",
"      ]. Doses between 2 and 5",
"      <span class=\"nowrap\">",
"       mcg/kg",
"      </span>",
"      per minute have variable effects on hemodynamics in individual patients: vasodilation is often balanced by increased stroke volume, producing little net effect upon systemic blood pressure. Some mild alpha adrenergic receptor activation increases SVR, and the sum of these effects is an increase in MAP.",
"     </li>",
"     <li>",
"      At doses &gt;10",
"      <span class=\"nowrap\">",
"       mcg/kg",
"      </span>",
"      per minute, the predominant effect of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?41/20/42310?source=see_link\">",
"       dopamine",
"      </a>",
"      is to stimulate alpha-adrenergic receptors and produce vasoconstriction with an increased SVR [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/35/40505/abstract/24,25\">",
"       24,25",
"      </a>",
"      ]. However, the overall alpha-adrenergic receptor effect of dopamine is weaker than that of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?16/28/16838?source=see_link\">",
"       norepinephrine",
"      </a>",
"      , and the beta-1 adrenergic receptor stimulation of dopamine at doses &gt;2",
"      <span class=\"nowrap\">",
"       mcg/kg",
"      </span>",
"      per minute can result in dose-limiting dysrhythmias.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In practical terms, the dose-dependent effects of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?41/20/42310?source=see_link\">",
"     dopamine",
"    </a>",
"    mean that changing the dose of the drug is akin to switching vasopressors. Conversely, simply increasing the dose of dopamine without being cognizant of the different receptor populations activated can cause untoward results.",
"   </p>",
"   <p>",
"    The usual dose range for",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?41/20/42310?source=see_link\">",
"     dopamine",
"    </a>",
"    is 2 to 20",
"    <span class=\"nowrap\">",
"     mcg/kg",
"    </span>",
"    per minute, although doses as high as 130",
"    <span class=\"nowrap\">",
"     mcg/kg",
"    </span>",
"    per minute have been employed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/35/40505/abstract/26\">",
"     26",
"    </a>",
"    ]. When used for cardiac failure, dopamine should be started at 2",
"    <span class=\"nowrap\">",
"     mcg/kg",
"    </span>",
"    per minute and then titrated to a desired physiologic effect rather than depending on the predicted pharmacologic ranges described above.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Dobutamine",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/57/25494?source=see_link\">",
"     Dobutamine",
"    </a>",
"    (Dobutrex) is not a vasopressor but rather is an inotrope that causes vasodilation. Dobutamine's predominant beta-1 adrenergic receptor effect increases inotropy and chronotropy and reduces left ventricular filling pressure. In patients with heart failure this results in a reduction in cardiac sympathetic activity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/35/40505/abstract/27\">",
"     27",
"    </a>",
"    ]. However, minimal alpha- and beta-2 adrenergic receptor effects result in overall vasodilation, complemented by reflex vasodilation to the increased CO. The net effect is increased CO, with decreased SVR with or without a small reduction in blood pressure.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/57/25494?source=see_link\">",
"     Dobutamine",
"    </a>",
"    is most frequently used in severe, medically refractory heart failure and cardiogenic shock and should not be routinely used in sepsis because of the risk of hypotension. Dobutamine does not selectively vasodilate the renal vascular bed, as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?41/20/42310?source=see_link\">",
"     dopamine",
"    </a>",
"    does at low doses. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/37/7769?source=see_link\">",
"     \"Inotropic agents in heart failure due to systolic dysfunction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Isoproterenol",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?22/31/23029?source=see_link\">",
"     Isoproterenol",
"    </a>",
"    (Isuprel) also is primarily an inotropic and chronotropic agent rather than a vasopressor. It acts upon beta-1 adrenergic receptors and, unlike",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/57/25494?source=see_link\">",
"     dobutamine",
"    </a>",
"    , has a prominent chronotropic effect. The drug's high affinity for the beta-2 adrenergic receptor causes vasodilation and a decrease in MAP. Therefore, its utility in hypotensive patients is limited to situations in which hypotension results from bradycardia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Contraindications and interactions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several conditions or medications require avoidance of specific agents:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In patients with cardiogenic shock,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?16/28/16838?source=see_link\">",
"       norepinephrine",
"      </a>",
"      is preferred over",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?41/20/42310?source=see_link\">",
"       dopamine",
"      </a>",
"      as the first-line vasopressor because a subgroup analysis from a randomized trial found that patients with cardiogenic shock who received dopamine had a higher mortality than those who received norepinephrine [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/35/40505/abstract/16,28\">",
"       16,28",
"      </a>",
"      ]. In addition, dysrhythmias were more common in the dopamine group.",
"     </li>",
"     <li>",
"      Patients with pheochromocytoma are at risk of excessive autonomic stimulation from adrenergic vasopressors.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/57/25494?source=see_link\">",
"       Dobutamine",
"      </a>",
"      is contraindicated in the setting of idiopathic hypertrophic subaortic stenosis.",
"     </li>",
"     <li>",
"      Patients receiving monoamine oxidase inhibitors are extremely sensitive to vasopressors and, therefore, require much lower doses.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     VASOPRESSIN AND ANALOGS",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?5/24/5511?source=see_link\">",
"     Vasopressin",
"    </a>",
"    (",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?5/24/5511?source=see_link\">",
"     antidiuretic hormone",
"    </a>",
"    ) is used in the management of diabetes insipidus and esophageal variceal bleeding; however, it may also be helpful in the management of vasodilatory shock. Although its precise role in vasodilatory shock remains to be defined, it is primarily used as a second-line agent in refractory vasodilatory shock, particularly septic shock or anaphylaxis that is unresponsive to epinephrine [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/35/40505/abstract/29-34\">",
"     29-34",
"    </a>",
"    ]. It is also used occasionally to reduce the dose of the first-line agent. Terlipressin, a vasopressin analog, has been assessed in patients with vasodilatory shock [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/35/40505/abstract/35-40\">",
"     35-40",
"    </a>",
"    ], but it is not available in the United States.",
"   </p>",
"   <p>",
"    The effects of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?5/24/5511?source=see_link\">",
"     vasopressin",
"    </a>",
"    and terlipressin in vasodilatory shock (mostly septic shock) were evaluated in a systematic review that identified 10 relevant randomized trials (1134 patients) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/35/40505/abstract/41\">",
"     41",
"    </a>",
"    ]. A meta-analysis of six of the trials (512 patients) compared vasopressin or terlipressin with placebo or supportive care. There was no significant improvement in short-term mortality among patients who received either vasopressin or terlipressin (40.2 versus 42.9 percent, relative risk 0.91, 95% CI 0.79-1.05). However, patients who received vasopressin or terlipressin required less",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?16/28/16838?source=see_link\">",
"     norepinephrine",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    The effects of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?5/24/5511?source=see_link\">",
"     vasopressin",
"    </a>",
"    may be dose dependent. A randomized trial compared two doses of vasopressin (0.0333 versus 0.067",
"    <span class=\"nowrap\">",
"     IU/min)",
"    </span>",
"    in 50 patients with vasodilatory shock who required vasopressin as a second pressor agent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/35/40505/abstract/42\">",
"     42",
"    </a>",
"    ]. The higher dose was more effective at increasing the blood pressure without increasing the frequency of adverse effects in these patients. However, doses of vasopressin above 0.03",
"    <span class=\"nowrap\">",
"     units/min",
"    </span>",
"    have been associated with coronary and mesenteric ischemia and skin necrosis in other studies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/35/40505/abstract/16,43-46\">",
"     16,43-46",
"    </a>",
"    ] and are avoided unless an adequate MAP cannot be attained with other vasopressor agents.",
"   </p>",
"   <p>",
"    Rebound hypotension appears to be common following withdrawal of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?5/24/5511?source=see_link\">",
"     vasopressin",
"    </a>",
"    . To avoid rebound hypotension, the dose is slowly tapered by 0.01",
"    <span class=\"nowrap\">",
"     units/min",
"    </span>",
"    every 30 minutes.",
"   </p>",
"   <p>",
"    Other potential adverse effects of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?5/24/5511?source=see_link\">",
"     vasopressin",
"    </a>",
"    include hyponatremia and pulmonary vasoconstriction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/35/40505/abstract/16,43-46\">",
"     16,43-46",
"    </a>",
"    ]. Terlipressin appears to have a similar side effect profile to vasopressin. In a meta-analysis of four trials (431 patients) that was conducted as part of the systematic review described above, there was no significant difference in the frequency of adverse events among patients who received either vasopressin or terlipressin (10.6 versus 11.8 percent, relative risk 0.90, 95% CI 0.49-1.67) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/35/40505/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24028105\">",
"    <span class=\"h1\">",
"     NONADRENERGIC AGENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of agents produce vasoconstriction or inotropy through nonadrenergic mechanisms, including phosphodiesterase inhibitors and nitric oxide synthase inhibitors.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     PDE inhibitors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Phosphodiesterase (PDE) inhibitors, such as inamrinone (formerly known as amrinone) and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?3/18/3366?source=see_link\">",
"     milrinone",
"    </a>",
"    , are nonadrenergic drugs with inotropic and vasodilatory actions. In many ways, their effects are similar to those of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/57/25494?source=see_link\">",
"     dobutamine",
"    </a>",
"    but with a lower incidence of dysrhythmias. PDE inhibitors most often are used to treat patients with impaired cardiac function and medically refractory heart failure, but their vasodilatory properties limit their use in hypotensive patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/35/40505/abstract/24\">",
"     24",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/37/7769?source=see_link\">",
"     \"Inotropic agents in heart failure due to systolic dysfunction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     NOS inhibitors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nitric oxide overproduction appears to play a major role in vasodilation induced by sepsis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/20/5449?source=see_link\">",
"     \"Pathophysiology of sepsis\"",
"    </a>",
"    .) Studies of nitric oxide synthase (NOS) inhibitors such as N-monomethyl-L-arginine (L-NMMA) in sepsis demonstrate a dose-dependent increase in SVR [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/35/40505/abstract/47\">",
"     47",
"    </a>",
"    ]. However, CI and HR decrease, even when patients are treated concomitantly with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?16/28/16838?source=see_link\">",
"     norepinephrine",
"    </a>",
"    or epinephrine. The increase in SVR tends to be offset by the drop in CI, such that MAP is only minimally augmented. The clinical utility of this class of drugs remains unproven.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vasopressors and inotropic agents have the potential to cause a number of significant complications, including hypoperfusion, dysrhythmias, myocardial ischemia, local effects, and hyperglycemia. In addition, a number of drug interactions exist.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Hypoperfusion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Excessive vasoconstriction in response to hypotension and vasopressors can produce inadequate perfusion of the extremities, mesenteric organs, or kidneys. Excessive vasoconstriction with inadequate perfusion, usually with an SVR &gt;1300 dynes x",
"    <span class=\"nowrap\">",
"     sec/cm",
"     <sup>",
"      5",
"     </sup>",
"     ,",
"    </span>",
"    commonly occurs in the setting of inadequate cardiac output or inadequate volume resuscitation.",
"   </p>",
"   <p>",
"    The initial findings are dusky skin changes at the tips of the fingers",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    toes, which may progress to frank necrosis with autoamputation of the digits. Compromise of the renal vascular bed may produce renal insufficiency and oliguria, while patients with underlying peripheral artery disease may develop acute limb ischemia.",
"   </p>",
"   <p>",
"    Inadequate mesenteric perfusion increases the risk of gastritis, shock liver, intestinal ischemia, or translocation of gut flora with resultant bacteremia. Despite these concerns, maintenance of MAP with vasopressors appears more effective in maintaining renal and mesenteric blood flow than allowing the MAP to drop, and maintenance of MAP with vasopressors may be life-saving despite evidence of localized hypoperfusion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/35/40505/abstract/15,48\">",
"     15,48",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     Dysrhythmias",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many vasopressors and inotropes exert powerful chronotropic effects via stimulation of beta-1 adrenergic receptors. This increases the risk of sinus tachycardia (most common), atrial fibrillation (potentially with increased A-V conduction and therefore an increased ventricular response), reentrant atrioventricular node tachycardia, or ventricular tachyarrhythmias.",
"   </p>",
"   <p>",
"    Adequate volume loading may minimize the frequency or severity of dysrhythmias. Despite this, dysrhythmias often limit the dose and necessitate switching to another agent with less prominent beta-1 effects. The degree to which the agent affects the frequency of dysrhythmias was illustrated by a randomized trial of 1679 patients with shock [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/35/40505/abstract/28\">",
"     28",
"    </a>",
"    ]. Dysrhythmias were significantly more common among patients who received",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?41/20/42310?source=see_link\">",
"     dopamine",
"    </a>",
"    than among those who received",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?16/28/16838?source=see_link\">",
"     norepinephrine",
"    </a>",
"    (24.1 versus 12.4 percent).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h2\">",
"     Myocardial ischemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;The chronotropic and inotropic effects of beta-adrenergic receptor stimulation can increase myocardial oxygen consumption. While there is usually coronary vasodilation in response to vasopressors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/35/40505/abstract/49\">",
"     49",
"    </a>",
"    ], perfusion may still be inadequate to accommodate the increased myocardial oxygen demand. Daily electrocardiograms on patients treated with vasopressors or inotropes may screen for occult ischemia, and excessive tachycardia should be avoided because of impaired diastolic filling of the coronary arteries.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h2\">",
"     Local effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;Peripheral extravasation of vasopressors into the surrounding connective tissue can lead to excessive local vasoconstriction with subsequent skin necrosis. To avoid this complication, vasopressors should be administered via a central vein whenever possible. If infiltration occurs, local treatment with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?33/43/34485?source=see_link\">",
"     phentolamine",
"    </a>",
"    (5 to 10 mg in 10 mL of normal saline) injected subcutaneously can minimize local vasoconstriction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/35/40505/abstract/50\">",
"     50",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h2\">",
"     Hyperglycemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hyperglycemia may occur due to the inhibition of insulin secretion. The magnitude of hyperglycemia generally is minor and is more pronounced with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?16/28/16838?source=see_link\">",
"     norepinephrine",
"    </a>",
"    and epinephrine than",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?41/20/42310?source=see_link\">",
"     dopamine",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/35/40505/abstract/21\">",
"     21",
"    </a>",
"    ]. Monitoring of blood glucose while on vasopressors can prevent complications of untreated hyperglycemia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h1\">",
"     CONTROVERSIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several controversies exist regarding the use of vasopressors and inotropic agents in critically ill patients. Most stem from the relative paucity of large-scale studies comparing similar patient populations treated with different regimens. The development of clear definitions for the systemic inflammatory response syndrome, sepsis, and septic shock is a step forward toward comparative trials among standardized patient populations. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/10/24744?source=see_link\">",
"     \"Sepsis and the systemic inflammatory response syndrome: Definitions, epidemiology, and prognosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H35\">",
"    <span class=\"h2\">",
"     Choice of agent in septic shock",
"    </span>",
"    &nbsp;&mdash;&nbsp;Numerous trials have compared one vasopressor to another in septic shock. Most of the comparisons have found no difference in mortality, length of stay in the ICU, or length of stay in the hospital [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/35/40505/abstract/51\">",
"     51",
"    </a>",
"    ]. These trials included",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?16/28/16838?source=see_link\">",
"     norepinephrine",
"    </a>",
"    versus",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/36/39488?source=see_link\">",
"     phenylephrine",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/35/40505/abstract/52\">",
"     52",
"    </a>",
"    ], norepinephrine versus",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?5/24/5511?source=see_link\">",
"     vasopressin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/35/40505/abstract/53-55\">",
"     53-55",
"    </a>",
"    ], norepinephrine versus terlipressin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/35/40505/abstract/35,56\">",
"     35,56",
"    </a>",
"    ], norepinephrine versus epinephrine [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/35/40505/abstract/57\">",
"     57",
"    </a>",
"    ], and vasopressin versus terlipressin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/35/40505/abstract/58\">",
"     58",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In contrast, a meta-analysis of six randomized trials (1408 patients) found increased mortality among patients who received",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?41/20/42310?source=see_link\">",
"     dopamine",
"    </a>",
"    during septic shock compared to those who received",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?16/28/16838?source=see_link\">",
"     norepinephrine",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/35/40505/abstract/11,28,48,59-62\">",
"     11,28,48,59-62",
"    </a>",
"    ]. Patients who received dopamine had a higher 28-day mortality rate than patients who received norepinephrine (54 versus 49 percent, relative risk 1.12, 95% CI 1.01-1.20). Although the causes of death in the two groups were not compared, arrhythmic events were two times more common with dopamine than norepinephrine. These findings were supported by another meta-analysis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/35/40505/abstract/63\">",
"     63",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Based on these data, it seems reasonable to choose a vasopressor on the basis of whether the patient has hyperdynamic or hypodynamic shock:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hyperdynamic septic shock is characterized by a low systemic vascular resistance and high cardiac index leading to hypotension and warm extremities (ie, \"warm sepsis\"). Vasopressors with prominent alpha vasoconstrictor effects (eg,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?16/28/16838?source=see_link\">",
"       norepinephrine",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?38/36/39488?source=see_link\">",
"       phenylephrine",
"      </a>",
"      ) are probably the most effective in this setting, since the predominant physiological abnormality is low systemic vascular resistance. Phenylephrine may be useful when tachycardia or dysrhythmias preclude the use of agents with beta-adrenergic activity.",
"     </li>",
"     <li>",
"      Hypodynamic septic shock is characterized by a low to modestly reduced systemic vascular resistance and low cardiac index leading to hypotension and decreased skin perfusion (ie, \"cold sepsis\").",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?16/28/16838?source=see_link\">",
"       Norepinephrine",
"      </a>",
"      is a reasonable first choice in such patients because its effects on beta-1 adrenergic receptors will increase the cardiac index and its effects on alpha-1 adrenergic receptors will cause vasoconstriction. For patients with persistent hypotension and a low cardiac output, an intotropic agent is often added. We typically add epinephrine in this situation, although",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/57/25494?source=see_link\">",
"       dobutamine",
"      </a>",
"      is an alternative. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Epinephrine'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H21\">",
"       'Dobutamine'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?5/24/5511?source=see_link\">",
"     Vasopressin",
"    </a>",
"    or terlipressin may be beneficial, when added to other vasopressor agents, such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?16/28/16838?source=see_link\">",
"     norepinephrine",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/35/40505/abstract/16\">",
"     16",
"    </a>",
"    ]. For patients who remain hypotensive despite two vasopressors, there is no evidence that adding a third vasopressor is superior to trying an alternative combination of vasopressors (ie, switching from norepinephrine plus vasopressin to norepinephrine plus",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/36/39488?source=see_link\">",
"     phenylephrine",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H38\">",
"    <span class=\"h2\">",
"     \"Renal dose\" dopamine",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?41/20/42310?source=see_link\">",
"     Dopamine",
"    </a>",
"    selectively increases renal blood flow when administered to normal volunteers at 1 to 3",
"    <span class=\"nowrap\">",
"     mcg/kg",
"    </span>",
"    per minute [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/35/40505/abstract/64,65\">",
"     64,65",
"    </a>",
"    ]. Animal studies also suggest that low-dose dopamine in the setting of vasopressor-dependent sepsis helps preserve renal blood flow [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/35/40505/abstract/66\">",
"     66",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/25/44435?source=see_link\">",
"     \"Renal actions of dopamine\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/10/42154?source=see_link\">",
"     \"Possible prevention and therapy of postischemic (ischemic) acute tubular necrosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, a beneficial effect of low or \"renal dose\"",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?41/20/42310?source=see_link\">",
"     dopamine",
"    </a>",
"    is less proven in human patients with sepsis or other critical illness. Critically ill patients who do not have evidence of renal insufficiency or decreased urine output will develop a diuresis in response to dopamine at 2 to 3",
"    <span class=\"nowrap\">",
"     mcg/kg",
"    </span>",
"    per minute, with variable effects on creatinine clearance, but the benefit of this diuresis is questionable [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/35/40505/abstract/9,23\">",
"     9,23",
"    </a>",
"    ]. The intervention is not entirely benign because hypotension and tachycardia may ensue. One small study demonstrated that the addition of low dose dopamine to patients receiving other vasopressors increases splanchnic blood flow but does not alter other indices of mesenteric perfusion, such as gastric intramucosal pH (pHi) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/35/40505/abstract/67\">",
"     67",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    At present, there are no data to support the routine use of low dose",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?41/20/42310?source=see_link\">",
"     dopamine",
"    </a>",
"    to prevent or treat acute renal failure or mesenteric ischemia. In general, the most effective means of protecting the kidneys in the setting of septic shock appears to be the maintenance of MAP &gt;60 mmHg while attempting to avoid excessive vasoconstriction (ie, the SVR should not exceed 1300 dynes x",
"    <span class=\"nowrap\">",
"     sec/cm",
"     <sup>",
"      5",
"     </sup>",
"     )",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/35/40505/abstract/6,11,68,69\">",
"     6,11,68,69",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H39\">",
"    <span class=\"h2\">",
"     Optimal dosage",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several studies have suggested improved tissue perfusion when higher doses of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?16/28/16838?source=see_link\">",
"     norepinephrine",
"    </a>",
"    (up to 350",
"    <span class=\"nowrap\">",
"     mcg/min)",
"    </span>",
"    are used [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/35/40505/abstract/11,69\">",
"     11,69",
"    </a>",
"    ]. However, no survival benefit of high-dose norepinephrine has been conclusively proven.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H40\">",
"    <span class=\"h2\">",
"     Supranormal cardiac index",
"    </span>",
"    &nbsp;&mdash;&nbsp;Elevation of the cardiac index with inotropic agents to supranormal values (ie, &gt;4.5",
"    <span class=\"nowrap\">",
"     L/minute",
"    </span>",
"    per m",
"    <sup>",
"     2",
"    </sup>",
"    ) potentially increases oxygen delivery to peripheral tissues. In theory, increased oxygen delivery may prevent tissue hypoxia and improve outcomes, and initial studies appeared to support this hypothesis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/35/40505/abstract/70-72\">",
"     70-72",
"    </a>",
"    ]. However, later larger trials showed that goal-oriented hemodynamic therapy to increase either cardiac index to &gt;4.5",
"    <span class=\"nowrap\">",
"     L/min",
"    </span>",
"    per m",
"    <sup>",
"     2",
"    </sup>",
"    or oxygen delivery to &gt;600 to 650",
"    <span class=\"nowrap\">",
"     mL/min",
"    </span>",
"    per m",
"    <sup>",
"     2",
"    </sup>",
"    with volume expansion or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/57/25494?source=see_link\">",
"     dobutamine",
"    </a>",
"    resulted in either no improvement or worsened morbidity or mortality [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/35/40505/abstract/12,13,73\">",
"     12,13,73",
"    </a>",
"    ]. Therefore, the routine administration of vasopressors or inotropes to improve cardiac output or oxygen delivery to supranormal levels is not advocated. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/44/31430?source=see_link\">",
"     \"Oxygen delivery and consumption\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The American Thoracic Society (ATS) statement on the detection, correction, and prevention of tissue hypoxia, as well as other ATS guidelines, can be accessed through the ATS web site at",
"    <a class=\"external\" href=\"file://www.thoracic.org/statements\">",
"     www.thoracic.org/statements",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H41\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Vasopressors are a powerful class of drugs that induce vasoconstriction and elevate mean arterial pressure. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Alpha-1, beta-1, and beta-2 adrenergic receptors induce vasoconstriction, inotropy plus chronotropy, and vasodilation, respectively. One subtype of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?41/20/42310?source=see_link\">",
"       dopamine",
"      </a>",
"      receptor induces",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?16/28/16838?source=see_link\">",
"       norepinephrine",
"      </a>",
"      release with subsequent vasoconstriction, although many dopamine receptors induce vasodilation. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Receptor physiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Vasopressors are indicated for a mean arterial pressure (MAP) &lt;60 mmHg, or a decrease of systolic blood pressure that exceeds 30 mmHg from baseline, when either condition results in end-organ dysfunction due to hypoperfusion. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Principles'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Hypovolemia should be corrected prior to the institution of vasopressor therapy for maximum efficacy. Patients should be reevaluated frequently once vasopressor therapy has been initiated. Common issues that arise include tachyphylaxis, which may require dose titration, and additional hemodynamic insults, which should be recognized and managed. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Practical Issues'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with hyperdynamic septic shock, we recommend",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?16/28/16838?source=see_link\">",
"       norepinephrine",
"      </a>",
"      as the first-line agent (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). Alternative agents include epinephrine or, for patients with tachyarrhythmias,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?38/36/39488?source=see_link\">",
"       phenylephrine",
"      </a>",
"      . Addition of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?5/24/5511?source=see_link\">",
"       vasopressin",
"      </a>",
"      may be of benefit if the adrenergic agent is inadequate. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Adrenergic agents'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H24028105\">",
"       'Nonadrenergic agents'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H35\">",
"       'Choice of agent in septic shock'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with hypodynamic shock, we suggest",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?16/28/16838?source=see_link\">",
"       norepinephrine",
"      </a>",
"      as the first-line agent. Patients should be closely monitored for lack of response and the need for the addition of an inotropic agent. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Adrenergic agents'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H35\">",
"       'Choice of agent in septic shock'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Epinephrine is the preferred agent for most patients with anaphylactic shock. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Adrenergic agents'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with cardiogenic shock,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?16/28/16838?source=see_link\">",
"       norepinephrine",
"      </a>",
"      is the preferred initial agent. Once an adequate perfusion pressure has been obtained,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/57/25494?source=see_link\">",
"       dobutamine",
"      </a>",
"      may be added, as tolerated. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Adrenergic agents'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?34/37/35418?source=see_link\">",
"       \"Prognosis and treatment of cardiogenic shock complicating acute myocardial infarction\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Complications of vasopressor therapy include hypoperfusion (particularly affecting the extremities, mesentery or kidneys), dysrhythmias, myocardial ischemia, peripheral extravasation with skin necrosis, and hyperglycemia. (See",
"      <a class=\"local\" href=\"#H28\">",
"       'Complications'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12836012\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The editorial staff at UpToDate, Inc. would like to acknowledge Dr. Nalaka Gooneratne, who contributed to an earlier version of this topic review.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/1\">",
"      M&uuml;llner M, Urbanek B, Havel C, et al. Vasopressors for shock. Cochrane Database Syst Rev 2004; :CD003709.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/2\">",
"      AHLQUIST RP. A study of the adrenotropic receptors. Am J Physiol 1948; 153:586.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/3\">",
"      ALLWOOD MJ, COBBOLD AF, GINSBURG J. Peripheral vascular effects of noradrenaline, isopropylnoradrenaline and dopamine. Br Med Bull 1963; 19:132.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/4\">",
"      Williamson AP, Seifen E, Lindemann JP, Kennedy RH. WB4101- and CEC-sensitive positive inotropic actions of phenylephrine in rat cardiac muscle. Am J Physiol 1994; 266:H2462.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/5\">",
"      Practice parameters for hemodynamic support of sepsis in adult patients in sepsis. Task Force of the American College of Critical Care Medicine, Society of Critical Care Medicine. Crit Care Med 1999; 27:639.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/6\">",
"      Moran JL, O'Fathartaigh MS, Peisach AR, et al. Epinephrine as an inotropic agent in septic shock: a dose-profile analysis. Crit Care Med 1993; 21:70.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/7\">",
"      Calvin JE, Driedger AA, Sibbald WJ. Does the pulmonary capillary wedge pressure predict left ventricular preload in critically ill patients? Crit Care Med 1981; 9:437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/8\">",
"      Packman MI, Rackow EC. Optimum left heart filling pressure during fluid resuscitation of patients with hypovolemic and septic shock. Crit Care Med 1983; 11:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/9\">",
"      Lherm T, Troch&eacute; G, Rossignol M, et al. Renal effects of low-dose dopamine in patients with sepsis syndrome or septic shock treated with catecholamines. Intensive Care Med 1996; 22:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/10\">",
"      Unverferth DA, Blanford M, Kates RE, Leier CV. Tolerance to dobutamine after a 72 hour continuous infusion. Am J Med 1980; 69:262.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/11\">",
"      Martin C, Papazian L, Perrin G, et al. Norepinephrine or dopamine for the treatment of hyperdynamic septic shock? Chest 1993; 103:1826.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/12\">",
"      Gattinoni L, Brazzi L, Pelosi P, et al. A trial of goal-oriented hemodynamic therapy in critically ill patients. SvO2 Collaborative Group. N Engl J Med 1995; 333:1025.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/13\">",
"      Hayes MA, Timmins AC, Yau EH, et al. Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med 1994; 330:1717.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/14\">",
"      D&ouml;rffler-Melly J, de Jonge E, Pont AC, et al. Bioavailability of subcutaneous low-molecular-weight heparin to patients on vasopressors. Lancet 2002; 359:849.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/15\">",
"      Gregory JS, Bonfiglio MF, Dasta JF, et al. Experience with phenylephrine as a component of the pharmacologic support of septic shock. Crit Care Med 1991; 19:1395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/16\">",
"      Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013; 41:580.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/17\">",
"      Yamazaki T, Shimada Y, Taenaka N, et al. Circulatory responses to afterloading with phenylephrine in hyperdynamic sepsis. Crit Care Med 1982; 10:432.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/18\">",
"      De Backer D, Creteur J, Silva E, Vincent JL. Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: which is best? Crit Care Med 2003; 31:1659.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/19\">",
"      MacGregor DA, Smith TE, Prielipp RC, et al. Pharmacokinetics of dopamine in healthy male subjects. Anesthesiology 2000; 92:338.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/20\">",
"      Goldberg LI. Dopamine--clinical uses of an endogenous catecholamine. N Engl J Med 1974; 291:707.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/21\">",
"      HORWITZ D, FOX SM 3D, GOLDBERG LI. Effects of Dopamine in man. Circ Res 1962; 10:237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/22\">",
"      Dasta JF, Kirby MG. Pharmacology and therapeutic use of low-dose dopamine. Pharmacotherapy 1986; 6:304.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/23\">",
"      Duke GJ, Briedis JH, Weaver RA. Renal support in critically ill patients: low-dose dopamine or low-dose dobutamine? Crit Care Med 1994; 22:1919.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/24\">",
"      L&ouml;llgen H, Drexler H. Use of inotropes in the critical care setting. Crit Care Med 1990; 18:S56.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/25\">",
"      Steel, A, Bihari, D. Choice of catecholamine: does it matter?. Curr Opin Crit Care 2000; 6:347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/26\">",
"      Hannemann L, Reinhart K, Grenzer O, et al. Comparison of dopamine to dobutamine and norepinephrine for oxygen delivery and uptake in septic shock. Crit Care Med 1995; 23:1962.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/27\">",
"      Al-Hesayen A, Azevedo ER, Newton GE, Parker JD. The effects of dobutamine on cardiac sympathetic activity in patients with congestive heart failure. J Am Coll Cardiol 2002; 39:1269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/28\">",
"      De Backer D, Biston P, Devriendt J, et al. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 2010; 362:779.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/29\">",
"      Mutlu GM, Factor P. Role of vasopressin in the management of septic shock. Intensive Care Med 2004; 30:1276.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/30\">",
"      Sharshar T, Blanchard A, Paillard M, et al. Circulating vasopressin levels in septic shock. Crit Care Med 2003; 31:1752.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/31\">",
"      Tsuneyoshi I, Yamada H, Kakihana Y, et al. Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock. Crit Care Med 2001; 29:487.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/32\">",
"      D&uuml;nser MW, Mayr AJ, Ulmer H, et al. Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study. Circulation 2003; 107:2313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/33\">",
"      Kill C, Wranze E, Wulf H. Successful treatment of severe anaphylactic shock with vasopressin. Two case reports. Int Arch Allergy Immunol 2004; 134:260.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/34\">",
"      Schummer C, Wirsing M, Schummer W. The pivotal role of vasopressin in refractory anaphylactic shock. Anesth Analg 2008; 107:620.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/35\">",
"      Alban&egrave;se J, Leone M, Delmas A, Martin C. Terlipressin or norepinephrine in hyperdynamic septic shock: a prospective, randomized study. Crit Care Med 2005; 33:1897.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/36\">",
"      Kam PC, Williams S, Yoong FF. Vasopressin and terlipressin: pharmacology and its clinical relevance. Anaesthesia 2004; 59:993.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/37\">",
"      O'Brien A, Clapp L, Singer M. Terlipressin for norepinephrine-resistant septic shock. Lancet 2002; 359:1209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/38\">",
"      Leone M, Alban&egrave;se J, Delmas A, et al. Terlipressin in catecholamine-resistant septic shock patients. Shock 2004; 22:314.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/39\">",
"      Rodr&iacute;guez-N&uacute;&ntilde;ez A, Fern&aacute;ndez-Sanmart&iacute;n M, Martin&oacute;n-Torres F, et al. Terlipressin for catecholamine-resistant septic shock in children. Intensive Care Med 2004; 30:477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/40\">",
"      Morelli A, Rocco M, Conti G, et al. Effects of terlipressin on systemic and regional haemodynamics in catecholamine-treated hyperkinetic septic shock. Intensive Care Med 2004; 30:597.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/41\">",
"      Polito A, Parisini E, Ricci Z, et al. Vasopressin for treatment of vasodilatory shock: an ESICM systematic review and meta-analysis. Intensive Care Med 2012; 38:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/42\">",
"      Torgersen C, D&uuml;nser MW, Wenzel V, et al. Comparing two different arginine vasopressin doses in advanced vasodilatory shock: a randomized, controlled, open-label trial. Intensive Care Med 2010; 36:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/43\">",
"      Malay MB, Ashton JL, Dahl K, et al. Heterogeneity of the vasoconstrictor effect of vasopressin in septic shock. Crit Care Med 2004; 32:1327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/44\">",
"      Kahn JM, Kress JP, Hall JB. Skin necrosis after extravasation of low-dose vasopressin administered for septic shock. Crit Care Med 2002; 30:1899.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/45\">",
"      Leather HA, Segers P, Berends N, et al. Effects of vasopressin on right ventricular function in an experimental model of acute pulmonary hypertension. Crit Care Med 2002; 30:2548.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/46\">",
"      D&uuml;nser MW, Mayr AJ, T&uuml;r A, et al. Ischemic skin lesions as a complication of continuous vasopressin infusion in catecholamine-resistant vasodilatory shock: incidence and risk factors. Crit Care Med 2003; 31:1394.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/47\">",
"      Petros A, Lamb G, Leone A, et al. Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc Res 1994; 28:34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/48\">",
"      Marik PE, Mohedin M. The contrasting effects of dopamine and norepinephrine on systemic and splanchnic oxygen utilization in hyperdynamic sepsis. JAMA 1994; 272:1354.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/49\">",
"      Bohr DF. Adrenergic receptors in coronary arteries. Ann N Y Acad Sci 1967; 139:799.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/50\">",
"      Peters, JI, Utset, OM. Vasopressors in shock management: Choosing and using wisely. J Crit Illness 1989; 4:62.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/51\">",
"      Havel C, Arrich J, Losert H, et al. Vasopressors for hypotensive shock. Cochrane Database Syst Rev 2011; :CD003709.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/52\">",
"      Morelli A, Ertmer C, Rehberg S, et al. Phenylephrine versus norepinephrine for initial hemodynamic support of patients with septic shock: a randomized, controlled trial. Crit Care 2008; 12:R143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/53\">",
"      Russell JA, Walley KR, Gordon AC, et al. Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock. Crit Care Med 2009; 37:811.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/54\">",
"      Lauzier F, L&eacute;vy B, Lamarre P, Lesur O. Vasopressin or norepinephrine in early hyperdynamic septic shock: a randomized clinical trial. Intensive Care Med 2006; 32:1782.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/55\">",
"      Luckner G, D&uuml;nser MW, Stadlbauer KH, et al. Cutaneous vascular reactivity and flow motion response to vasopressin in advanced vasodilatory shock and severe postoperative multiple organ dysfunction syndrome. Crit Care 2006; 10:R40.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/56\">",
"      Boccara G, Ouattara A, Godet G, et al. Terlipressin versus norepinephrine to correct refractory arterial hypotension after general anesthesia in patients chronically treated with renin-angiotensin system inhibitors. Anesthesiology 2003; 98:1338.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/57\">",
"      Myburgh JA, Higgins A, Jovanovska A, et al. A comparison of epinephrine and norepinephrine in critically ill patients. Intensive Care Med 2008; 34:2226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/58\">",
"      Morelli A, Ertmer C, Rehberg S, et al. Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study. Crit Care 2009; 13:R130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/59\">",
"      De Backer D, Aldecoa C, Njimi H, Vincent JL. Dopamine versus norepinephrine in the treatment of septic shock: a meta-analysis*. Crit Care Med 2012; 40:725.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/60\">",
"      Patel GP, Grahe JS, Sperry M, et al. Efficacy and safety of dopamine versus norepinephrine in the management of septic shock. Shock 2010; 33:375.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/61\">",
"      Mathur SM, Dhunna R, Chakraborty A. Comparison of dopamine and norepinephrine in the management of septic shock using impedance cardiography. Ind J Crit Care Med 2007; 11:186.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/62\">",
"      Ruokonen E, Takala J, Kari A, et al. Regional blood flow and oxygen transport in septic shock. Crit Care Med 1993; 21:1296.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/63\">",
"      Vasu TS, Cavallazzi R, Hirani A, et al. Norepinephrine or dopamine for septic shock: systematic review of randomized clinical trials. J Intensive Care Med 2012; 27:172.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/64\">",
"      Hollenberg NK, Adams DF, Mendell P, et al. Renal vascular responses to dopamine: haemodynamic and angiographic observations in normal man. Clin Sci Mol Med 1973; 45:733.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/65\">",
"      D'Orio V, el Allaf D, Juchm&egrave;s J, Marcelle R. The use of low doses of dopamine in intensive care medicine. Arch Int Physiol Biochim 1984; 92:S11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/66\">",
"      Schaer GL, Fink MP, Parrillo JE. Norepinephrine alone versus norepinephrine plus low-dose dopamine: enhanced renal blood flow with combination pressor therapy. Crit Care Med 1985; 13:492.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/67\">",
"      Meier-Hellmann A, Bredle DL, Specht M, et al. The effects of low-dose dopamine on splanchnic blood flow and oxygen uptake in patients with septic shock. Intensive Care Med 1997; 23:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/68\">",
"      Meadows D, Edwards JD, Wilkins RG, Nightingale P. Reversal of intractable septic shock with norepinephrine therapy. Crit Care Med 1988; 16:663.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/69\">",
"      Redl-Wenzl EM, Armbruster C, Edelmann G, et al. The effects of norepinephrine on hemodynamics and renal function in severe septic shock states. Intensive Care Med 1993; 19:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/70\">",
"      Shoemaker WC, Kram HB, Appel PL. Therapy of shock based on pathophysiology, monitoring, and outcome prediction. Crit Care Med 1990; 18:S19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/71\">",
"      Russell JA, Phang PT. The oxygen delivery/consumption controversy. Approaches to management of the critically ill. Am J Respir Crit Care Med 1994; 149:533.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/72\">",
"      Tuchschmidt J, Fried J, Astiz M, Rackow E. Elevation of cardiac output and oxygen delivery improves outcome in septic shock. Chest 1992; 102:216.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/35/40505/abstract/73\">",
"      Al&iacute;a I, Esteban A, Gordo F, et al. A randomized and controlled trial of the effect of treatment aimed at maximizing oxygen delivery in patients with severe sepsis or septic shock. Chest 1999; 115:453.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1619 Version 13.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-183.1.191.153-42B8F45CE1-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_35_40505=[""].join("\n");
var outline_f39_35_40505=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H41\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      RECEPTOR PHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Alpha adrenergic",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Beta adrenergic",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Dopamine",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      PRINCIPLES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      PRACTICAL ISSUES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Volume resuscitation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Selection and titration",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Route of administration",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Tachyphylaxis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Hemodynamic effects",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Subcutaneous delivery of medications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Frequent reevaluation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      ADRENERGIC AGENTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H376789843\">",
"      Norepinephrine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Phenylephrine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Epinephrine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Ephedrine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Dopamine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Dobutamine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Isoproterenol",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Contraindications and interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      VASOPRESSIN AND ANALOGS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24028105\">",
"      NONADRENERGIC AGENTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      PDE inhibitors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      NOS inhibitors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Hypoperfusion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      Dysrhythmias",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      Myocardial ischemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      Local effects",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      Hyperglycemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      CONTROVERSIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H35\">",
"      Choice of agent in septic shock",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H38\">",
"      \"Renal dose\" dopamine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H39\">",
"      Optimal dosage",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H40\">",
"      Supranormal cardiac index",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H41\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12836012\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PULM/1619\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/1619|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?32/5/32860\" title=\"table 1\">",
"      Vasoactive receptor activity",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   CALCULATORS",
"  </h1>",
"  <div id=\"relatedCalculators\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"mobipreview.htm?25/56/26497?source=related_link\" title=\"calculator 1\">",
"      Calculator: Systemic Vascular Resistance",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/1/29?source=related_link\">",
"      Complications of central venous catheters and their prevention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/51/21306?source=related_link\">",
"      Evaluation and management of severe sepsis and septic shock in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/37/7769?source=related_link\">",
"      Inotropic agents in heart failure due to systolic dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/32/44553?source=related_link\">",
"      Overview of central venous access",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/44/31430?source=related_link\">",
"      Oxygen delivery and consumption",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/20/5449?source=related_link\">",
"      Pathophysiology of sepsis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/10/42154?source=related_link\">",
"      Possible prevention and therapy of postischemic (ischemic) acute tubular necrosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/37/35418?source=related_link\">",
"      Prognosis and treatment of cardiogenic shock complicating acute myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/10/44199?source=related_link\">",
"      Pulmonary artery catheterization: Interpretation of tracings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/25/44435?source=related_link\">",
"      Renal actions of dopamine",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/10/24744?source=related_link\">",
"      Sepsis and the systemic inflammatory response syndrome: Definitions, epidemiology, and prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/62/6120?source=related_link\">",
"      Shock in adults: Types, presentation, and diagnostic approach",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/20/13639?source=related_link\">",
"      Treatment of severe hypovolemia or hypovolemic shock in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f39_35_40506="Old inferior MI tutorial";
var content_f39_35_40506=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F81282&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F81282&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1254px;\">",
"  <div class=\"figure\" style=\"width: 540px\">",
"   <div class=\"ttl\">",
"    Chronic inferior wall myocardial infarction",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 520px; height: 130px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A chronic inferior wall infarct is characterized by the presence of initial Q waves which are deep and broad in the inferior leads 2, 3, aVF.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 594px\">",
"   <div class=\"ttl\">",
"    Normal ECG",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 594px; height: 337px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Normal electrocardiogram showing normal sinus rhythm at a rate of 75 beats/min, a PR interval of 0.14 sec, a QRS interval of 0.10 sec, and a QRS axis of approximately 75&deg;.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Ary Goldberger, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_35_40506=[""].join("\n");
var outline_f39_35_40506=null;
var title_f39_35_40507="Sex reassignment surgery eligibility and readiness criteria";
var content_f39_35_40507=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F60865&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F60865&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Sex reassignment surgery eligibility and readiness criteria",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Individuals treated with cross-sex hormones are considered eligible for sex reassignment surgery if they:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        1. Are of the legal age of majority in their nation.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        2. Have used cross-sex hormones continuously and responsibly during 12 months (if they have no medical contraindication).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        3. Had a successful continuous full-time real life experience (RLE) during 12 months.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        4. Have (if required by the mental health professional [MHP]) regularly participated in psychotherapy throughout the RLE at a frequency determined jointly by the patient and the MHP.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        5. Have shown demonstrable knowledge of all practical aspects of surgery (eg, cost, required lengths of hospitalizations, likely complications, postsurgical rehabilitation, etc).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Individuals treated with cross-sex hormones should fulfill the following readiness criteria prior to sex reassignment surgery:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        1. Demonstrable progress in consolidating one's gender identity.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        2. Demonstrable progress in dealing with work, family, and interpersonal issues, resulting in a significantly better state of mental health.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Hembree WC, Cohen-Kettenis P, Delemarre-van de Waal HA, et al. Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2009; 94:3132. Copyright &copy; 2009 The Endocrine Society.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_35_40507=[""].join("\n");
var outline_f39_35_40507=null;
var title_f39_35_40508="Anticoagulation regimens in pregnancy";
var content_f39_35_40508=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F56377&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F56377&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Anticoagulation regimen definitions",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Management type",
"       </td>",
"       <td class=\"subtitle1\">",
"        Dosage",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"3\">",
"        Prophylactic LMWH*",
"       </td>",
"       <td>",
"        Enoxaparin, 40 mg SC once daily",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Dalteparin, 5000 units SC once daily",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Tinzaparin, 4500 units SC once daily",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"4\">",
"        <p>",
"         Therapeutic LMWH",
"         <sup>",
"          &bull;",
"         </sup>",
"        </p>",
"        <p>",
"         (Also referred to as weight-adjusted, full-treatment dose)",
"        </p>",
"       </td>",
"       <td>",
"        Enoxaparin, 1 mg/kg every 12 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Dalteparin, 200 units/kg once daily",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Tinzaparin, 175 units/kg once daily",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Dalteparin, 100 units/kg every 12 hours",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Minidose prophylactic UFH",
"       </td>",
"       <td>",
"        UFH, 5000 units SC every 12 hours",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"4\">",
"        Prophylactic UFH",
"       </td>",
"       <td>",
"        UFH, 5000-10,000 units SC every 12 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        UFH, 5000-7500 units SC every 12 hours in first trimester",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        UFH, 7500-10,000 units SC every 12 hours in the second trimester",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        UFH, 10,000 units SC every 12 hours in the third trimester, unless the aPTT is elevated",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        <p>",
"         Therapeutic UFH",
"        </p>",
"        <p>",
"         (Also referred to as weight-adjusted, full-treatment dose)",
"        </p>",
"       </td>",
"       <td>",
"        UFH, 10,000 units or more SC every 12 hours in doses adjusted to target aPTT in the therapeutic range (1.5-2.5, 6 hours after injection)",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"3\">",
"        Postpartum anticoagulation",
"       </td>",
"       <td>",
"        Prophylactic LMWH/UFH for 4-6 weeks",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         OR",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vitamin K antagonists for 4-6 weeks with a target INR of 2.0-3.0, with initial UFH or LMWH therapy overlap until the INR is 2.0 or more for 2 days",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Surveillance",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     LMWH: low molecular weight heparin; SC: subcutaneously; UFH: unfractionated heparin; aPTT: activated partial thromboplastin time; INR: international normalized ratio.",
"     <br>",
"      * Although at extremes of body weight, modification of dose may be required.",
"      <br>",
"       <span class=\"bullet\">",
"        &bull;",
"       </span>",
"       May target an anti-Xa level in the therapeutic range of 0.6-1.0 units/mL for twice daily regimen; slightly higher doses may be needed for a once-daily regimen.",
"       <br>",
"        &Delta; Clinical vigilance and appropriate objective investigation of women with symptoms suspicious of deep vein thrombosis or pulmonary embolism may be needed.",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: ACOG Practice Bulletin #123. Thromboembolism in pregnancy. Obstet Gynecol 2011; 118:718. Copyright &copy; 2011 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_35_40508=[""].join("\n");
var outline_f39_35_40508=null;
var title_f39_35_40509="Pediatric headache diary";
var content_f39_35_40509=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F78869&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F78869&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Pediatric headache diary",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Date/",
"        <br/>",
"        time start/time finish",
"       </td>",
"       <td class=\"subtitle1\">",
"        Location*/quality",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td class=\"subtitle1\">",
"        Severity",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td class=\"subtitle1\">",
"        Symptoms before headache",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"       <td class=\"subtitle1\">",
"        Trigger(s)",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"       <td class=\"subtitle1\">",
"        Associated features",
"        <sup>",
"         &yen;",
"        </sup>",
"       </td>",
"       <td class=\"subtitle1\">",
"        Relieving factors",
"        <sup>",
"         ",
"        </sup>",
"       </td>",
"       <td class=\"subtitle1\">",
"        Full, partial, or no relief?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Left side, right side, both sides, front, back, behind eye, all around head.",
"     <br>",
"      <span class=\"bullet\">",
"       &bull;",
"      </span>",
"      Throbbing (pulsating), dull, squeezing/tightening, splitting, stabbing, etc.",
"      <br>",
"       &Delta; Rate from 1 to 10, with 10 being the most severe.",
"       <br>",
"        <span class=\"lozenge\">",
"         &loz;",
"        </span>",
"        Flashing lights, blind spots, blurred vision, nausea, numbness, tingling, etc.",
"        <br>",
"         &sect; Foods, odors, light, heat, exercise, traveling in car, lack of sleep, etc.",
"         <br>",
"          &yen; Nausea, vomiting, numbness, tingling, weakness, etc.",
"          <br>",
"            Medication (including dose), sleep, inactivity, darkness, cold compresses, etc.",
"          </br>",
"         </br>",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_35_40509=[""].join("\n");
var outline_f39_35_40509=null;
var title_f39_35_40510="Allergic mucin";
var content_f39_35_40510=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F67108&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F67108&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Gross appearance of allergic mucin",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 151px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Mark S. Schubert, MD, PhD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_35_40510=[""].join("\n");
var outline_f39_35_40510=null;
var title_f39_35_40511="Keratosis pilaris";
var content_f39_35_40511=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F72338&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F72338&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 509px\">",
"   <div class=\"ttl\">",
"    Keratosis pilaris",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 489px; height: 305px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Inflamed follicles and papules are evident on the arm.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Beth G Goldstein, MD and Adam O Goldstein, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_35_40511=[""].join("\n");
var outline_f39_35_40511=null;
